Pacific Mercantile Bancorp (PMBC) 10-Q 7 May 21 2021 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2021	May 06, 2021
Document Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2021
Document Transition Report	false
Entity File Number	0-30777
Entity Registrant Name	PACIFIC MERCANTILE BANCORP
Entity Incorporation, State	CA
Entity Tax Identification Number	33-0898238
Entity Address, Street Address	949 South Coast Drive
Entity Address, Suite	Suite 300
Entity Address, City	Costa Mesa
Entity Address, State	CA
Entity Address, Postal Zip Code	92626
City Area Code	714
Local Phone Number	438-2500
Title of each class	Common Stock, without par value
Trading Symbol(s)	PMBC
Name of each exchange on which registered	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001109546
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Amendment Flag	false
Common Stock
Document Information
Entity Common Stock, Shares Outstanding		22,322,184
Nonvoting Common Stock
Document Information
Entity Common Stock, Shares Outstanding		1,467,155

CONSOLIDATED STATEMENTS OF FINA

CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
ASSETS
Cash and due from banks	$ 18,487	$ 12,024
Interest bearing deposits with financial institutions	239,899	274,245
Cash and cash equivalents	258,386	286,269
Interest-bearing time deposits with financial institutions	1,597	1,597
Federal Reserve Bank of San Francisco and Federal Home Loan Bank Stock, at cost	7,910	7,910
Securities available for sale, at fair value	43,228	42,183
Loans (net of allowances of $17,127 and $17,452, respectively)	1,227,645	1,209,587
Accrued interest receivable	6,667	5,666
Premises and equipment, net	712	779
Net deferred tax assets	8,989	8,502
Intangible assets	370	389
Other assets	24,533	24,708
Total assets	1,580,037	1,587,590
Deposits:
Noninterest-bearing	649,407	647,115
Interest-bearing	734,364	736,232
Total deposits	1,383,771	1,383,347
Borrowings	0	10,000
Accrued interest payable	144	188
Other liabilities	17,324	17,779
Junior subordinated debentures	17,527	17,527
Total liabilities	1,418,766	1,428,841
Commitments and contingencies (Note 11)
Shareholders’ equity:
Common stock, no par value, 85,000,000 shares of voting common stock and 2,000,000 shares of non-voting common stock authorized; 22,320,230 and 22,191,260 voting shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively; 1,467,155 non-voting shares issued and outstanding at March 31, 2021 and December 31, 2020	154,749	154,454
Retained earnings	7,767	4,379
Accumulated other comprehensive loss	(1,245)	(84)
Total shareholders’ equity	161,271	158,749
Total liabilities and shareholders’ equity	$ 1,580,037	$ 1,587,590

CONSOLIDATED STATEMENTS OF FI_2

CONSOLIDATED STATEMENTS OF FINANCIAL CONDITION (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Loans, allowances	$ 17,127	$ 17,452
Common stock, no par value	$ 0	$ 0
Common Stock
Common stock, shares authorized (in shares)	85,000,000	85,000,000
Common stock, shares issued (in shares)	22,320,230	22,191,260
Common stock, shares outstanding (in shares)	22,320,230	22,191,260
Nonvoting Common Stock
Common stock, shares authorized (in shares)	2,000,000	2,000,000
Common stock, shares issued (in shares)	1,467,155	1,467,155
Common stock, shares outstanding (in shares)	1,467,155	1,467,155

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Interest income:
Loans, including fees	$ 13,331	$ 13,787
Securities available for sale and stock	315	261
Interest-bearing deposits with financial institutions	52	721
Total interest income	13,698	14,769
Interest expense:
Deposits	825	2,965
Borrowings	134	331
Total interest expense	959	3,296
Net interest income	12,739	11,473
Provision for loan and lease losses	0	6,200
Net interest income after provision for loan and lease losses	12,739	5,273
Noninterest income
Service fees on deposits and other banking services	819	522
Net gain on sale of securities available for sale	140	0
Net (loss) gain on sale of other assets	(45)	6
Other noninterest income	824	567
Total noninterest income	1,738	1,095
Noninterest expense
Salaries and employee benefits	5,661	6,069
Occupancy	656	671
Equipment and depreciation	495	452
Data processing	562	645
FDIC expense	285	193
Professional fees	882	861
Merger related expenses	387	0
Business development	121	172
Loan related expense	158	125
Insurance	71	63
Other operating expense	386	469
Total noninterest expense	9,664	9,720
Income (loss) before income taxes	4,813	(3,352)
Income tax expense (benefit)	1,425	(991)
Net income (loss) allocable to common shareholders	$ 3,388	$ (2,361)
Basic income per common share:
Net income (loss) allocable to common shareholders (in dollars per share)	$ 0.14	$ (0.10)
Diluted income per common share:
Net income (loss) allocable to common shareholders (in dollars per share)	$ 0.14	$ (0.10)
Weighted average number of common shares outstanding:
Basic (in shares)	23,561,643	23,475,042
Diluted (in shares)	23,813,329	23,475,042

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 3,388	$ (2,361)
Other comprehensive income (loss), net of tax:
Change in unrealized holding (loss) gain on securities available for sale	(1,063)	547
Less: Reclassification adjustment for net gains included in net income	98	0
Net unrealized holding (loss) gain on securities available for sale	(1,161)	547
Total comprehensive income	$ 2,227	$ (1,814)

CONSOLIDATED STATEMENTS OF SHAR

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common stock	Retained earnings (Accumulated deficit)	Accumulated other comprehensive income (loss)
Beginning balance at Dec. 31, 2018				$ (1,144)
Increase (Decrease) in Stockholders' Equity
Other comprehensive income (loss)				577
Ending balance at Dec. 31, 2019	$ 149,048	$ 153,570	$ (3,955)	(567)
Ending balance (in shares) at Dec. 31, 2019		23,574,000
Increase (Decrease) in Stockholders' Equity
Issuance of restricted stock, net	0
Issuance of restricted stock, net (in shares)		19,000
Common stock based compensation expense	214	$ 214
Common stock options exercised	$ 50	$ 50
Common stock options exercised (in shares)	10,728	11,000
Net income (loss)	$ (2,361)		(2,361)
Other comprehensive income (loss)	547			547
Ending balance at Mar. 31, 2020	147,498	$ 153,834	(6,316)	(20)
Ending balance (in shares) at Mar. 31, 2020		23,604,000
Beginning balance at Dec. 31, 2019	149,048	$ 153,570	(3,955)	(567)
Beginning balance (in shares) at Dec. 31, 2019		23,574,000
Increase (Decrease) in Stockholders' Equity
Other comprehensive income (loss)				483
Ending balance at Dec. 31, 2020	158,749	$ 154,454	4,379	(84)
Ending balance (in shares) at Dec. 31, 2020		23,658,000
Increase (Decrease) in Stockholders' Equity
Issuance of restricted stock, net	0
Issuance of restricted stock, net (in shares)		113,000
Common stock based compensation expense	226	$ 226
Common stock options exercised	$ 69	$ 69
Common stock options exercised (in shares)	16,000	16,000
Net income (loss)	$ 3,388		3,388
Other comprehensive income (loss)	(1,161)			(1,161)
Ending balance at Mar. 31, 2021	$ 161,271	$ 154,749	$ 7,767	$ (1,245)
Ending balance (in shares) at Mar. 31, 2021		23,787,000

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash Flows From Operating Activities:
Net income (loss)	$ 3,388	$ (2,361)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	82	101
Provision for loan and lease losses	0	6,200
Amortization of premium on securities	35	33
Net gain on sale of securities available for sale	(140)	0
Net amortization accretion of deferred fees and unearned income on loans	(1,000)	(186)
Net loss on sale of other assets	45	6
Stock-based compensation expense	226	214
Changes in operating assets and liabilities:
Net (increase) decrease in accrued interest receivable	(1,001)	12
Net (increase) decrease in other assets	401	42
Net (increase) decrease in deferred taxes	0	(812)
Net (increase) decrease in income taxes receivable	(229)	195
Net (decrease) increase in accrued interest payable	(44)	(30)
Net (decrease) increase in other liabilities	(455)	(1,154)
Net cash provided by operating activities	1,308	2,260
Cash Flows From Investing Activities:
Net decrease in interest-bearing time deposits with financial institutions	0	75
Maturities of and principal payments received on securities available for sale and other stock	1,830	1,375
Purchase of securities available for sale and other stock	(10,119)	0
Proceeds from sale of securities available for sale and other stock	5,701	0
Purchase of other investments	(58)	0
Net increase in loans	(17,058)	(18,493)
Purchases of premises and equipment	(15)	(121)
Proceeds from sale of other assets	35	0
Net cash used in investing activities	(19,684)	(17,164)
Cash Flows From Financing Activities:
Net increase in deposits	424	96,718
Proceeds from borrowings	0	110,000
Payments of borrowings	(10,000)	(20,000)
Proceeds from exercise of common stock options	69	50
Net cash provided by (used in) financing activities	(9,507)	186,768
Net change in cash and cash equivalents	(27,883)	171,864
Cash and Cash Equivalents, beginning of period	286,269	220,138
Cash and Cash Equivalents, end of period	258,386	392,002
Supplementary Cash Flow Information:
Cash paid for interest on deposits and other borrowings	1,003	3,326
Cash paid for income taxes	0	17
Noncash Investing Activities:
Transfer of loans into other assets	$ 0	$ 315

Nature of Business

Nature of Business	3 Months Ended
	Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business	Nature of Business Organization Pacific Mercantile Bancorp (“PMBC”) is a bank holding company which, through its wholly owned subsidiary, Pacific Mercantile Bank (the “Bank”), is engaged in the commercial banking business in Southern California. PMBC is registered as a one bank holding company under the United States Bank Holding Company Act of 1956, as amended, and, as such, is regulated by the Board of Governors of the Federal Reserve System (the “Federal Reserve Board”) and the Federal Reserve Bank of San Francisco (“FRBSF”) under delegated authority from the Federal Reserve Board. Substantially all of our operations are conducted and substantially all of our assets are owned by the Bank, which accounts for substantially all of our consolidated revenues, expenses, and income. The Bank provides a full range of banking services to middle-market businesses and professionals primarily in Orange, Los Angeles, San Bernardino and San Diego counties in Southern California and is subject to competition from, among other things, other banks and financial institutions and from financial services organizations conducting operations in those same markets. The Bank is chartered by the California Department of Financial Protection and Innovation under the Division of Financial Institutions and is a member of the FRBSF. In addition, the deposit accounts of the Bank’s customers are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to the maximum amount allowed by law. PMBC and the Bank are sometimes referred to, together, on a consolidated basis, in this report as the “Company” or as “we”, “us” or “our”. On March 22, 2021, PMBC entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Banc of California, Inc., a Maryland corporation (“Banc of California”). The Merger Agreement provides that, upon the terms and subject to the conditions set forth therein, PMBC will merge with and into Banc of California (the “Merger”), with Banc of California surviving the Merger. Promptly following the Merger, the Bank will merge with and into Banc of California’s wholly-owned bank subsidiary, Banc of California, National Association, a national banking association (the “Bank Merger”). Banc of California, National Association will be the surviving bank in the Bank Merger. The Merger Agreement was adopted and approved by the Board of Directors of each of PMBC and Banc of California. The closing of the Merger, which is expected to occur in the third quarter of 2021, is contingent upon shareholder approvals and receipt of necessary regulatory approvals, along with the satisfaction of other customary closing conditions.

Significant Accounting Policies

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Significant Accounting Policies	Significant Accounting Policies Except as discussed below, our accounting policies are described in Note 2, Significant Accounting Policies of our audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020 (as amended, the “Form 10-K”). Interim Consolidated Financial Statements Basis of Presentation Our interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in effect in the United States (“GAAP”) for interim financial information pursuant to rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”), including instructions to Form 10-Q and Article 10 of Regulation S-X, on a basis consistent with prior periods. Our financial statements reflect all adjustments that are, in the opinion of management, necessary to present a fair statement of the results for the interim periods presented. All such adjustments were of a normal and recurring nature. The interim results are not necessarily indicative of operating results for the full year. The interim information should be read in conjunction with our audited consolidated financial statements in our Form 10-K. Use of Estimates The preparation of the financial statements in conformity with GAAP requires us to make certain estimates and assumptions that could affect the reported amounts of certain of our assets, liabilities, and contingencies at the date of the financial statements and the reported amounts of our revenues and expenses during the reporting periods. For the fiscal periods covered by this report, those estimates related primarily to our determinations of the allowance for loan and lease losses (“ALLL”), the fair values of securities available for sale, and the determination of the valuation allowance pertaining to deferred tax assets. If circumstances or financial trends on which those estimates were based were to change in the future or there were to occur any currently unanticipated events affecting the amounts of those estimates, our future financial position or results of operations could differ, possibly materially, from those expected at the current time. Principles of Consolidation Our consolidated financial statements as of March 31, 2021 and December 31, 2020 and for the three months ended March 31, 2021 and 2020 include the accounts of PMBC and the Bank. All significant intercompany balances and transactions were eliminated in consolidation. Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires the measurement of all expected credit losses for financial assets held at the reporting date, based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions will now use forward-looking information to better inform their credit loss estimates. Additionally, the ASU amends the accounting guidance for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. On November 15, 2019, the FASB issued ASU 2019-10, "Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates " which finalizes various effective date delays for private companies, not-for-profit organizations, and smaller reporting companies applying the credit losses (CECL), leases, and hedging standards. The effective date for smaller reporting companies has been delayed from the interim and annual periods beginning after December 15, 2020 to the interim and annual periods beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning after December 15, 2018. We plan to adopt this guidance on January 1, 2023 and expect that it will have a material impact on the determination of our ALLL. We are unable to estimate the expected impact to the ALLL upon adoption due to various factors, primarily the fine tuning of our qualitative assumptions used within our preliminary model, uncertainty regarding economic conditions and the size and mix of our loan portfolio at the time of adoption, which could impact our historical loss factors. We are currently working with our existing ALLL software provider on further developing the model to perform the ALLL calculations upon adoption and we believe that we currently have in place the internal team capable of handling this implementation. In December 2019, the FASB issued ASU 2019-12, " Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes," which eliminates certain exceptions to the guidance in ASC 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance is effective for public business entities for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. We adopted this guidance on January 1, 2021, and do not expect any material impact related to this pronouncement. In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting," which provides temporary optional expedients to ease the financial reporting burdens of the expected market transition from London Interbank Offered Rate (LIBOR) to an alternative reference rate such as Secured Overnight Financing Rate (SOFR). The guidance was effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating this guidance to determine the date of adoption and the impact on the Company. In October 2020, the FASB issued ASU 2020-08, "Codification Improvements to Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs," which clarified that for each reporting period, an entity should reevaluate whether a callable debt security is within the scope of paragraph 310-20-35-33 of the FASB Accounting Standards Codification. This guidance is effective for public business entities for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. We adopted this guidance on January 1, 2021.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Under FASB Accounting Standards Codification (“ASC”) 820-10, we group assets and liabilities at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. These levels are: Level 1 Valuation is based upon quoted prices for identical instruments traded in active markets. Level 2 Valuation is based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Level 3 Valuation is generated from model-based techniques that use at least one significant assumption not observable in the market. These unobservable assumptions reflect estimates of assumptions that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow models and similar techniques. Risks with Fair Value Measurements Fair value estimates are made at a discrete point in time based on relevant market information and other information about the financial instruments. Because no active market exists for a significant portion of our financial instruments, fair value estimates are based in large part on judgments we make primarily regarding current economic conditions, risk characteristics of various financial instruments, prepayment rates, and future expected loss experience. These estimates are subjective in nature and invariably involve some inherent uncertainties. Additionally, the occurrence of unexpected events or changes in circumstances can occur that could require us to make changes to our assumptions and which, in turn, could significantly affect and require us to make changes to our previous estimates of fair value. In addition, the fair value estimates are based on existing on and off-balance sheet financial instruments without attempting to estimate the value of existing and anticipated future customer relationships and the value of assets and liabilities that are not considered financial instruments, such as premises and equipment and other real estate owned (“OREO”). Measurement Methodology Cash and Cash Equivalents. The fair value of cash and cash equivalents approximates its carrying value. Interest-Bearing Deposits with Financial Institutions. The fair values of interest-bearing deposits maturing within one year approximate their carrying values. FHLB and FRBSF Stock. The Bank is a member of the Federal Home Loan Bank of San Francisco (“FHLB”) and the FRBSF. As members, we are required to own stock of the FHLB and the FRBSF, the amount of which is based primarily on the level of our borrowings from those institutions. We also have the right to acquire additional shares of stock in either or both of the FHLB and the FRBSF. During the three months ended March 31, 2021, we purchased no FHLB or FRBSF stock. No shares of FHLB stock or FRBSF stock were called during the three months ended March 31, 2021. The fair values of the FHLB and FRBSF stock are equal to their respective carrying amounts, are classified as restricted securities and are periodically evaluated for impairment based on our assessment of the ultimate recoverability of our investments in that stock. Any cash or stock dividends paid to us on such stock are reported as income. Investment Securities Available for Sale. Fair value measurement for our investment securities available for sale is based upon quoted prices, if available. If quoted prices are not available, fair values are measured using independent pricing models or other model-based valuation techniques such as the present value of future cash flows, adjusted for the security’s credit rating, prepayment assumptions and other factors such as credit loss assumptions. Level 1 investment securities include those traded on an active exchange, such as the New York Stock Exchange, and U.S. Treasury securities that are traded by dealers or brokers in active over-the-counter markets. Level 2 investment securities include mortgage-backed securities issued by government sponsored entities, municipal bonds and corporate debt securities. Securities classified as Level 3 include asset-backed securities in less liquid markets. Equity Investments Without Readily Determinable Fair Value . Equity investments without readily determinable fair value are accounted for under the measurement alternative method of accounting. These investments are measured at cost, less any impairment, plus or minus any changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Any cash or stock dividends paid to us on such investments are reported as noninterest income. Impaired Loans . Loans measured for impairment are measured at an observable market price (if available), or the fair value of the loan’s collateral (if the loan is collateral dependent). The fair value of an impaired loan may be estimated using one of several methods, including collateral value, market value of similar debt, liquidation value and discounted cash flows. Those impaired loans not requiring a specific loan loss reserve represent loans for which the fair value of the expected repayments or collateral exceeds the recorded investments in such loans. When the fair value of the collateral is based on an observable market price or a current appraised value, we record the impaired loan at Level 2. When an appraised value is not available or we determine that the fair value of the collateral is further impaired below the appraised value and there is no observable market price, we record the impaired loan at Level 3. Loans . The fair value for loans with variable interest rates less a credit discount is the carrying amount. The fair value of fixed rate loans is derived by calculating the present value of expected future cash flows discounted at the loan’s original interest rate by the various homogeneous categories of loans. All loans have been adjusted to reflect changes in credit risk and represent the exit price of the loans. Changes are not recorded directly as an adjustment to current earnings or comprehensive income, but rather as an adjustment component in determining the overall adequacy of the loan loss reserve. Other Real Estate Owned. OREO is reported at its net realizable value (fair value less estimated costs to sell) at the time any real estate collateral is acquired by the Bank in satisfaction of a loan. Subsequently, OREO is carried at the lower of carrying value or fair value less estimated costs to sell. Fair value is determined based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral. When the fair value of the collateral is based on an observable market price or a current appraised value, we record the foreclosed asset at Level 2. When an appraised value is not available or management determines the fair value of the collateral is further impaired below the appraised value and there is no observable market price, we record the foreclosed asset at Level 3. Other Foreclosed Assets. Other foreclosed assets are reported at their net realizable value (fair value less estimated costs to sell) at the time any collateral other than real estate is acquired by the Bank in satisfaction of a loan. Subsequently, other foreclosed assets are carried at the lower of carrying value or fair value less estimated costs to sell. Fair value is determined based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral. When the fair value of the collateral is based on an observable market price or a current appraised value, we record the foreclosed asset at Level 2. When an appraised value is not available or management determines the fair value of the collateral is further impaired below the appraised value and there is no observable market price, we record the foreclosed asset at Level 3. Deposits. Deposits are carried at historical cost. The carrying amounts of deposits from savings and money market accounts are deemed to approximate fair value as they either have no stated maturities or short-term maturities. Certificates of deposit are estimated utilizing discounted cash flow techniques. The interest rates applied are rates currently being offered for similar certificates of deposit. Borrowings. The fair value of borrowings is the carrying amount for those borrowings that mature on a daily basis. The fair value of term borrowings is derived by calculating the discounted value of future cash flows expected to be paid out by the Company. We classify our borrowings in Level 2 of the fair value hierarchy. Junior Subordinated Debentures. The fair value of the junior subordinated debentures is based on quoted market prices of the underlying securities. These securities are variable rate in nature and repriced quarterly. We classify our junior subordinated debentures in Level 2 of the fair value hierarchy. Commitments to Extend Credit and Standby Letters of Credit. The fair value of commitments to extend credit and standby letters of credit are based on fees currently charged to enter into similar agreements, taking into account the remaining terms of the agreements and the counterparties’ credit standing. Interest Receivable and Interest Payable. The carrying amounts of our accrued interest receivable and accrued interest payable are deemed to approximate fair value. Assets Recorded at Fair Value on a Recurring Basis The following tables show the recorded amounts of assets and liabilities measured at fair value on a recurring basis at March 31, 2021 and December 31, 2020: At March 31, 2021 (Dollars in thousands) Total Level 1 Level 2 Level 3 Assets at Fair Value: Debt securities available for sale Commercial mortgage backed securities issued by U.S. agencies $ 27,390 $ — $ 27,390 $ — Residential mortgage backed securities issued by U.S. agencies 7,854 — 7,854 — Corporate subordinated debt 7,984 — 7,984 — Total debt securities available for sale at fair value $ 43,228 $ — $ 43,228 $ — At December 31, 2020 (Dollars in thousands) Total Level 1 Level 2 Level 3 Assets at Fair Value: Debt securities available for sale Commercial mortgage backed securities issued by U.S. agencies $ 20,673 $ — $ 20,673 $ — Residential mortgage backed securities issued by U.S. agencies 14,436 — 14,436 — Corporate subordinated debt 7,074 — 7,074 — Total debt securities available for sale at fair value $ 42,183 $ — $ 42,183 $ — Assets Recorded at Fair Value on a Nonrecurring Basis We may be required, from time to time, to measure certain assets at fair value on a nonrecurring basis in accordance with GAAP. These nonrecurring fair value adjustments typically involve application of the lower of cost or market accounting or write-downs of individual assets. Information regarding assets measured at fair value on a nonrecurring basis is set forth in the table below. At March 31, 2021 At December 31, 2020 (Dollars in thousands) Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Assets at Fair Value: Impaired loans $ 26,148 $ — $ — $ 26,148 $ 39,916 $ — $ — $ 39,916 Other foreclosed assets 152 — 152 — 231 — 231 — Total $ 26,300 $ — $ 152 $ 26,148 $ 40,147 $ — $ 231 $ 39,916 Significant Unobservable Inputs and Valuation Techniques of Level 3 Fair Value Measurements For our fair value measurements classified in Level 3 of the fair value hierarchy as of March 31, 2021, a summary of the significant unobservable inputs and valuation techniques is as follows: Fair Value Measurement as of March 31, 2021 Valuation Techniques (2) Unobservable Inputs (2) Range Weighted Average (Dollars in thousands) Assets Impaired loans $ 26,148 Third-Party Pricing Discounted cash flow N/A (1) N/A (1) (1) As part of our process, we obtain appraisals for our various properties included within impaired loans which primarily rely upon market comparisons. These market comparisons support our assumption that the carrying value of the respective loans either requires or does not require additional impairment. (2) As of March 31, 2021, there has been no change to our valuation techniques or the types of unobservable inputs used in the calculation of fair value from December 31, 2020. Fair Value Measurements for Other Financial Instruments The table below provides estimated fair values and related carrying amounts of our financial instruments as of March 31, 2021 and December 31, 2020, excluding financial assets and liabilities which are recorded at fair value on a recurring basis. Estimated Fair Value At March 31, 2021 At December 31, 2020 Carrying Value Total Level 1 Level 2 Level 3 Carrying Value Total Level 1 Level 2 Level 3 (Dollars in thousands) Financial assets: Cash and cash equivalents $ 258,386 $ 258,386 $ 258,386 $ — $ — $ 286,269 $ 286,269 286,269 — — Interest-bearing deposits with financial institutions 1,597 1,597 1,597 — — 1,597 1,597 1,597 — — Federal Reserve Bank of San Francisco and Federal Home Loan Bank stock 7,910 7,910 7,910 — — 7,910 7,910 7,910 — — Loans, net 1,227,645 1,238,435 — — 1,238,435 1,209,587 1,218,096 — — 1,218,096 Accrued interest receivable 6,667 6,667 6,667 — — 5,666 5,666 5,666 — — Financial liabilities: Noninterest bearing deposits 649,407 649,407 649,407 — — 647,115 647,115 647,115 — — Interest-bearing deposits 734,364 735,228 — 735,228 — 736,232 737,888 — 737,888 — FHLB borrowings — — — — — 10,000 10,009 — 10,009 — Junior subordinated debentures 17,527 17,527 — 17,527 — 17,527 17,527 — 17,527 — Accrued interest payable 144 144 144 — — 188 188 188 — —

Investments

Investments	3 Months Ended
	Mar. 31, 2021
Investments [Abstract]
Investments	Investments Securities Available For Sale, at Fair Value The following table sets forth the major components of securities available for sale and compares the amortized costs and estimated fair market values of, and the gross unrealized gains and losses on, these securities at March 31, 2021 and December 31, 2020: (Dollars in thousands) March 31, 2021 December 31, 2020 Amortized Gross Unrealized Estimated Amortized Gross Unrealized Estimated Gain Loss Gain Loss Securities Available for Sale Commercial mortgage backed securities issued by U.S. Agencies (1) $ 28,578 $ 95 $ (1,283) $ 27,390 $ 20,585 $ 214 $ (126) $ 20,673 Residential mortgage backed securities issued by U.S. Agencies (2) 7,763 94 (3) 7,854 14,061 379 (4) 14,436 Corporate subordinated debt 8,033 27 (76) 7,984 7,035 42 (3) 7,074 Total $ 44,374 $ 216 $ (1,362) $ 43,228 $ 41,681 $ 635 $ (133) $ 42,183 (1) Secured by first liens on commercial apartment building mortgages. (2) Secured by closed-end first liens on 1-4 family residential mortgages. At March 31, 2021 and December 31, 2020, U.S. agency residential mortgage backed securities with an aggregate fair market value of $1.6 million and $2.0 million, respectively, were pledged to secure repurchase agreements, local agency deposits and treasury, tax and loan accounts. The amortized cost and estimated fair values of securities available for sale at March 31, 2021 and December 31, 2020 are shown in the tables below by contractual maturities taking into consideration historical prepayments based on the prior twelve months of principal payments. Expected maturities will differ from contractual maturities and historical prepayments, particularly with respect to collateralized mortgage obligations, primarily because prepayment rates are affected by changes in conditions in the interest rate market and, therefore, future prepayment rates may differ from historical prepayment rates. At March 31, 2021 Maturing in (Dollars in thousands) One year Over one Over five Over ten Total Securities available for sale, amortized cost $ 3,539 $ 17,430 $ 11,210 $ 12,195 $ 44,374 Securities available for sale, estimated fair value 3,558 17,490 10,900 11,280 43,228 Weighted average yield 1.24 % 2.45 % 1.14 % 1.40 % 1.73 % At December 31, 2020 Maturing in (Dollars in thousands) One year Over one Over five Over ten Total Securities available for sale, amortized cost $ 5,657 $ 19,953 $ 6,368 $ 9,703 $ 41,681 Securities available for sale, estimated fair value 5,770 20,353 6,422 9,638 42,183 Weighted average yield 1.27 % 2.27 % 1.27 % 1.38 % 1.77 % We purchased $10.0 million of securities available for sale during the three months ended March 31, 2021 and no securities available for sale during the three months ended March 31, 2020. We sold $5.7 million of securities available for sale during the three months ended March 31, 2021, for a total net gain on sale of $140 thousand. We had no sales of securities available for sale during the three months ended March 31, 2020. The tables below indicate, as of March 31, 2021 and December 31, 2020, the gross unrealized losses and fair values of our investments, aggregated by investment category, and length of time that the individual securities have been in a continuous unrealized loss position. Securities with Unrealized Loss at March 31, 2021 Less than 12 months 12 months or more Total (Dollars in thousands) Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized Commercial mortgage backed securities issued by U.S. Agencies $ 7,105 $ (1,283) $ — $ — $ 7,105 $ (1,283) Residential mortgage backed securities issued by U.S. Agencies 65 (1) 124 (2) 189 (3) Corporate subordinated debt 3,957 (76) — — 3,957 (76) Total $ 11,127 $ (1,360) $ 124 $ (2) $ 11,251 $ (1,362) Securities with Unrealized Loss at December 31, 2020 Less than 12 months 12 months or more Total (Dollars in thousands) Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized Commercial mortgage backed securities issued by U.S. Agencies $ 7,483 $ (126) $ — $ — $ 7,483 $ (126) Residential mortgage backed securities issued by U.S. Agencies 68 (1) 126 (3) 194 (4) Corporate subordinated debt 4,032 (3) — — 4,032 (3) Total $ 11,583 $ (130) $ 126 $ (3) $ 11,709 $ (133) We regularly monitor investments for significant declines in fair value. We have determined that declines in the fair values of these investments below their respective amortized costs, as set forth in the tables above, are temporary because (i) those declines were due to interest rate changes and not to a deterioration in the creditworthiness of the issuers of those investment securities, and (ii) we have the ability to hold those securities until there is a recovery in their values or until their maturity. We recognize other-than-temporary impairments (“OTTI”) to our available-for-sale debt securities in accordance with FASB ASC 320-10. When there are credit losses associated with, but we have no intention to sell, an impaired debt security, and it is more likely than not that we will not have to sell the security before recovery of its cost basis, we will separate the amount of impairment, or OTTI, between the amount that is credit-related and the amount that is related to non-credit factors. Credit-related impairments are recognized in our consolidated statements of operations. Any non-credit-related impairments are recognized and reflected in other comprehensive income in our consolidated statements of financial condition. Through the impairment assessment process, we determined that there were no available-for-sale debt securities that were other-than-temporarily impaired at March 31, 2021. We recorded no impairment credit losses on available-for-sale debt securities in our consolidated statements of operations for the three months ended March 31, 2021 and 2020. We have made a determination that the remainder of our securities with respect to which there were unrealized losses as of March 31, 2021 are not other-than-temporarily impaired, because we have concluded that we have the ability to continue to hold those securities until their respective fair market values increase above their respective amortized costs or, if necessary, until their respective maturities. In reaching that conclusion we considered a number of factors and other information, which included: (i) the significance of each such security, (ii) the amount of the unrealized losses attributable to each such security, (iii) our liquidity position, (iv) the impact that retention of those securities could have on our capital position and (v) our evaluation of the expected future performance of these securities (based on the criteria discussed above). Equity Investments Without Readily Determinable Fair Value As of March 31, 2021, we had three investments in private companies and limited partnerships without a readily determinable fair value. As of March 31, 2021, we owned less than 3% of the total investment in each such company or partnership. Under ASU 2016-01, we elected to measure these equity investments using the measurement alternative, which requires that these investments are measured at cost, less any impairment, plus or minus any changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. During the three months ended March 31, 2021, these investments were not impaired and there were no observable price changes. As a result, the balance shown below as of March 31, 2021 represents the cost of the investments and is included within other assets on the consolidated statements of financial condition. During the three months ended March 31, 2021, we had $58 thousand of net capital contributions to these investments. We had zero capital contributions to these investments during the three months ended March 31, 2020. As of March 31, 2021 and December 31, 2020, our equity investments without readily determinable fair value were as follows: March 31, 2021 December 31, 2020 (Dollars in thousands) Equity investments without readily determinable fair value $ 2,731 $ 2,673

Loans and Allowance for Loan an

Loans and Allowance for Loan and Lease Losses	3 Months Ended
	Mar. 31, 2021
Receivables [Abstract]
Loans and Allowance for Loan and Lease Losses	90 Days and Accruing (Dollars in thousands) At March 31, 2021 Commercial loans, excluding PPP $ 1,367 $ 80 $ 578 $ 2,025 $ 319,294 $ 321,319 $ — Commercial loans - PPP — — — — 280,562 280,562 — Commercial real estate loans – owner-occupied — — — — 189,203 189,203 — Commercial real estate loans – — — — — 197,026 197,026 — Residential mortgage loans – — — — — 157,646 157,646 — Residential mortgage loans – — — — — 10,085 10,085 — Construction and land development loans — — — — 11,840 11,840 — Consumer loans 89 13 45 147 76,522 76,669 — Total $ 1,456 $ 93 $ 623 $ 2,172 $ 1,242,178 $ 1,244,350 $ — At December 31, 2020 Commercial loans, excluding PPP $ 5,281 $ 3,646 $ 9,670 $ 18,597 $ 318,830 $ 337,427 $ 5,675 Commercial loans - PPP — — — — 229,728 229,728 — Commercial real estate loans – owner-occupied — — — — 197,336 197,336 — Commercial real estate loans – — — 1,837 1,837 193,056 194,893 — Residential mortgage loans – — — — — 159,182 159,182 — Residential mortgage loans – — — — — 12,766 12,766 — Construction and land development loans — — — — 11,766 11,766 — Consumer loans — 65 — 65 80,694 80,759 — Total $ 5,281 $ 3,711 $ 11,507 $ 20,499 $ 1,203,358 $ 1,223,857 $ 5,675 Generally, the accrual of interest on a loan is discontinued when principal or interest payments become more than 90 days past due, unless we believe that the loan is adequately collateralized and it is in the process of collection. There were no loans 90 days or more past due and still accruing interest at March 31, 2021, and $5.7 million loans 90 days or more past due and still accruing interest at December 31, 2020. In certain instances, when a loan is placed on nonaccrual status, previously accrued but unpaid interest is reversed against current income. Subsequent collections of cash are applied as principal reductions when received (referred to as full nonaccrual basis of accounting), except when the ultimate collectability of principal is probable, in which case such payments are applied to accrued and unpaid interest, which is credited to income (referred to as nonaccrual cash basis of accounting). Nonaccrual loans may be restored to accrual status when principal and interest become current and full repayment becomes expected. The following table provides information with respect to loans on nonaccrual status, by portfolio type, as of March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 (Dollars in thousands) Nonaccrual loans: Commercial loans $ 19,426 $ 30,928 Commercial real estate loans – owner occupied 952 6,978 Commercial real estate loans – all other — 1,836 Consumer 181 174 Total (1) $ 20,559 $ 39,916 (1) Nonaccrual loans may include loans that are currently considered performing loans. We classify our loan portfolio using internal asset quality ratings. The following table provides a summary of loans by portfolio type and our internal asset quality ratings as of March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 (Dollars in thousands) Pass: Commercial loans, excluding PPP $ 271,240 $ 263,616 Commercial loans - PPP 280,562 229,728 Commercial real estate loans – owner occupied 167,057 162,250 Commercial real estate loans – all other 196,243 192,264 Residential mortgage loans – multi family 156,678 158,816 Residential mortgage loans – single family 10,085 12,766 Construction and land development loans 11,340 11,766 Consumer loans 76,481 80,576 Total pass loans $ 1,169,686 $ 1,111,782 Special Mention: Commercial loans $ 10,667 $ 13,763 Commercial real estate loans – owner occupied — 6,882 Commercial real estate loans – all other — 793 Residential mortgage loans – multi family 969 366 Total special mention loans $ 11,636 $ 21,804 Substandard: Commercial loans $ 39,305 $ 59,408 Commercial real estate loans – owner occupied 22,145 28,203 Commercial real estate loans – all other 783 1,837 Construction and land development loans 500 — Consumer loans 188 182 Total substandard loans $ 62,921 $ 89,630 Doubtful: Commercial loans $ 107 $ 641 Total doubtful loans $ 107 $ 641 Total Loans: $ 1,244,350 $ 1,223,857 Impaired Loans A loan generally is classified as impaired when, in our opinion, principal or interest is not likely to be collected in accordance with the contractual terms of the loan agreement. We measure for impairments on a loan-by-loan basis, using either the present value of expected future cash flows discounted at the loan’s effective interest rate, or the fair value of the collateral if the loan is collateral dependent. The following table sets forth information regarding impaired loans, at March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 (Dollars in thousands) Impaired loans: Nonaccruing loans $ 17,064 $ 33,204 Nonaccruing restructured loans 3,495 6,712 Accruing restructured loans (1) 5,589 — Total impaired loans $ 26,148 $ 39,916 Impaired loans less than 90 days delinquent and included in total impaired loans $ 25,525 $ 34,085 (1) See “ Troubled Debt Restructurings ” below for a description of accruing restructured loans at March 31, 2021 and December 31, 2020. The table below contains additional information with respect to impaired loans, by portfolio type, as of March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 Recorded Investment Unpaid Principal Balance Related Allowance (1) Recorded Investment Unpaid Principal Balance Related Allowance (1) (Dollars in thousands) No allowance recorded: Commercial loans, excluding PPP $ 5,627 $ 11,935 $ — $ 10,970 $ 19,530 $ — Commercial real estate loans – owner occupied 5,479 6,198 — 6,978 7,633 — Commercial real estate loans – all other — — — 1,836 1,837 — Consumer loans 181 222 — 174 197 — Total $ 11,287 $ 18,355 $ — $ 19,958 $ 29,197 $ — With allowance recorded: Commercial loans, excluding PPP $ 14,861 $ 15,041 $ 1,962 $ 19,958 $ 20,040 $ 2,711 Total $ 14,861 $ 15,041 $ 1,962 $ 19,958 $ 20,040 $ 2,711 All impaired loans Commercial loans, excluding PPP $ 20,488 $ 26,976 $ 1,962 $ 30,928 $ 39,570 $ 2,711 Commercial real estate loans – owner occupied 5,479 6,198 — 6,978 7,633 — Commercial real estate loans – all other — — — 1,836 1,837 — Consumer loans 181 222 — 174 197 — Total $ 26,148 $ 33,396 $ 1,962 $ 39,916 $ 49,237 $ 2,711 (1) When the discounted cash flows, collateral value or market price equals or exceeds the recorded investment in the loan, then specific reserves are not required to be set aside for the loan within the ALLL. This typically occurs when the impaired loans have been partially charged-off and/or there have been interest payments received and applied to the balance of the principal outstanding. At March 31, 2021 and December 31, 2020, there were $11.3 million and $20.0 million, respectively, of impaired loans for which no specific reserves had been allocated because these loans, in our judgment, were sufficiently collateralized. Of the impaired loans at March 31, 2021 for which no specific reserves were allocated, $8.6 million had been deemed impaired in the prior year. Average balances and interest income recognized on impaired loans, by portfolio type, for the three months ended March 31, 2021 and 2020 were as follows: Three Months Ended March 31, 2021 2020 Average Balance Interest Income Recognized Average Balance Interest Income Recognized (Dollars in thousands) No allowance recorded: Commercial loans, excluding PPP $ 8,298 $ 54 $ 10,178 $ — Commercial real estate loans – owner occupied 6,228 — 6,438 — Commercial real estate loans – all other 918 — — — Consumer loans 178 — 130 — Total 15,622 54 16,746 — With allowance recorded: Commercial loans, excluding PPP 17,410 1,105 — Total 17,410 — 1,105 — Total Commercial loans, excluding PPP 25,708 54 11,283 — Commercial real estate loans – owner occupied 6,228 — 6,438 — Commercial real estate loans – all other 918 — — — Consumer loans 178 — 130 — Total $ 33,032 $ 54 $ 17,851 $ — The interest that would have been earned had the impaired loans remained current in accordance with their original terms was $424 thousand and $574 thousand during the three months ended March 31, 2021 and 2020, respectively. Troubled Debt Restructurings (“TDRs”) Pursuant to the FASB's ASU No. 2011-2, A Creditor’s Determination of whether a Restructuring is a Troubled Debt Restructuring , the Bank's TDRs totaled $9.1 million at March 31, 2021. There were $6.7 million TDRs as of December 31, 2020. TDRs consist of loans to which modifications have been made for the purpose of alleviating temporary impairments of the borrower's financial condition and cash flows. Those modifications have come in the form of changes in amortization terms, reductions in interest rates, interest only payments and, in limited cases, concessions to outstanding loan balances. The modifications are made as part of workout plans we enter into with the borrower that are designed to provide a bridge for the borrower’s cash flow shortfalls in the near term. If a borrower works through the near term issues, then in most cases, the original contractual terms of the borrower’s loan will be reinstated. TDRs do not include short term loan modifications made on a good faith basis in response to COVID-19, per Section 4013, Temporary Relief from Troubled Debt Restructurings , of the CARES Act. There were no loans restructured as TDRs during the three months ended March 31, 2020. The following table presents loans restructured as TDRs during the three months ended March 31, 2021 and 2020: Three Months Ended March 31, 2021 March 31, 2020 (Dollars in thousands) Number of Pre-Modification Post-Modification Number of Pre-Modification Post-Modification Performing Commercial loans 2 $ 2,639 $ 1,062 — $ — $ — Commercial real estate – owner occupied 1 4,929 4,527 — — — 3 7,568 5,589 — — — Nonperforming Commercial loans 5 $ 5,266 $ 3,495 — $ — $ — 5 5,266 3,495 — — — Total Troubled Debt Restructurings (1) 8 $ 12,834 $ 9,084 — $ — $ — (1) No outstanding loans were restructured during the three months ended March 31, 2020." id="sjs-B4">Loans and Allowance for Loan and Lease Losses The loan portfolio consisted of the following at: March 31, 2021 December 31, 2020 Amount Percent Amount Percent (Dollars in thousands) Commercial loans, excluding PPP $ 321,319 25.8 % $ 337,427 27.6 % Commercial loans - PPP 280,562 22.5 % 229,728 18.8 % Commercial real estate loans – owner occupied 189,203 15.2 % 197,336 16.1 % Commercial real estate loans – all other 197,026 15.8 % 194,893 15.9 % Residential mortgage loans – multi-family 157,646 12.7 % 159,182 13.0 % Residential mortgage loans – single family 10,085 0.8 % 12,766 1.0 % Construction and land development loans 11,840 1.0 % 11,766 1.0 % Consumer loans 76,669 6.2 % 80,759 6.6 % Gross loans 1,244,350 100.0 % 1,223,857 100.0 % Deferred costs, net 422 3,182 Allowance for loan and lease losses (17,127) (17,452) Loans, net $ 1,227,645 $ 1,209,587 At March 31, 2021, commercial loans included $280.6 million of loans originated through the Paycheck Protection Program ("PPP"), which is administered by the Small Business Administration ("SBA") and was established by the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act"), and subsequently modified by the Paycheck Protection Program Flexibility Act ("PPPFA"). The PPP loans are 100% guaranteed by the SBA and the principal and interest may be forgiven by the SBA if the borrower demonstrates that the loan proceeds were used as prescribed by the governing legislation and regulations during either an 8-week or 24-week period following funding (the "Covered Period"). Borrowers began submitting applications for forgiveness in the third quarter of 2020 and have until 10 months following the end of their Covered Period to apply. As of March 31, 2021, $96.9 million of our originated PPP loans have been forgiven by the SBA. At March 31, 2021 and December 31, 2020, real estate loans of approximately $439 million and $434 million, respectively, were pledged to secure borrowings obtained from the FHLB and to support our unfunded borrowing capacity. At March 31, 2021 and December 31, 2020, commercial and consumer loans of $130 million and $146 million, respectively, were pledged to secure borrowings from the FRB to support our unfunded borrowing capacity. No loans were sold or purchased during the three months ended March 31, 2021 and March 31, 2020. Allowance for Loan and Lease Losses The ALLL represents our estimate of credit losses in our loan and lease portfolio that are probable and estimable at the balance sheet date. We employ economic models that are based on bank regulatory guidelines, industry standards and our own historical loan loss experience, as well as a number of more subjective qualitative factors, to determine both the sufficiency of the ALLL and the amount of the provisions that are required to increase or replenish the ALLL. The ALLL is first determined by (i) analyzing all classified loans (graded as “Substandard” or “Doubtful” under our internal asset quality grading parameters) on nonaccrual status for loss exposure and (ii) establishing specific reserves as needed. ASC 310-10 defines loan impairment as the existence of uncertainty concerning collection of all principal and interest in accordance with the contractual terms of a loan. For collateral dependent loans, impairment is typically measured by comparing the loan amount to the fair value of collateral, less estimated costs to sell, with any “shortfall” amount charged off. Other methods can be used in estimating impairment, including market price and the present value of expected future cash flows discounted at the loan’s original interest rate. We are an active lender with the U.S. Small Business Administration and collection of a percentage of the loan balance of many of the loans originated is guaranteed. The ALLL reserves are calculated against the non-guaranteed loan balances. On a quarterly basis, we utilize a classification based loan loss migration model as well as review individual loans in determining the adequacy of the ALLL for homogenous pools of loans that are not subject to specific reserve allocations. Our loss migration analysis utilizes a series of nineteen staggered 16-quarter migration periods of loan loss history and industry loss factors to determine historical losses by classification category for each loan type, except certain consumer loans (automobile, mortgage and credit cards). We then apply these calculated loss factors, together with qualitative factors based on external economic conditions and trends and internal assessments, to the outstanding loan balances in each homogenous group of loans, and then, using our internal asset quality grading parameters, we grade the loans as “Pass,” “Special Mention,” “Substandard” or “Doubtful”. We analyze impaired loans individually. This grading is based on the credit classifications of assets as prescribed by government regulations and industry standards and is separated into the following groups: • Pass: Loans classified as pass include current loans performing in accordance with contractual terms, installment/consumer loans that are not individually risk rated, and loans which exhibit certain risk factors that require greater than usual monitoring by management. • Special Mention: Loans classified as special mention, while generally not delinquent, have potential weaknesses that deserve management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or in the Bank’s credit position at some future date. • Substandard: Loans classified as substandard have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. There is a distinct possibility that the Bank will sustain some loss if the deficiencies are not corrected. • Doubtful: Loans classified as doubtful have all the weaknesses inherent in a substandard loan, and may also be at delinquency status and have defined weaknesses based on currently existing facts, conditions and values making collection or liquidation in full highly questionable and improbable. Set forth below is a summary of the activity in the ALLL, by portfolio type, during the three months ended March 31, 2021 and 2020: Commercial Commercial Real Estate Construction and Land Consumer Unallocated Total (Dollars in thousands) ALLL in the three months ended March 31, 2021: Balance at beginning of period $ 11,255 $ — $ 3,964 $ 137 $ 2,096 $ — $ 17,452 Charge offs (525) — — — (13) — (538) Recoveries 209 — — — 4 — 213 Provision (316) — 489 29 (202) — — Balance at end of period $ 10,623 $ — $ 4,453 $ 166 $ 1,885 $ — $ 17,127 ALLL in the three months ended March 31, 2020: Balance at beginning of period $ 8,883 $ — $ 2,897 $ 34 $ 1,797 $ — $ 13,611 Charge offs (2,250) — — — (64) — (2,314) Recoveries 19 — — — 4 — 23 Provision 4,566 — 1,471 21 142 — 6,200 Balance at end of period $ 11,218 $ — $ 4,368 $ 55 $ 1,879 $ — $ 17,520 Set forth below is information regarding loan balances and the related ALLL, by portfolio type, as of March 31, 2021 and December 31, 2020. Commercial Commercial Real Estate Construction and Land Consumer Unallocated Total (Dollars in thousands) ALLL balance at March 31, 2021 related to: Loans individually evaluated for impairment $ 1,962 $ — $ — $ — $ — $ — $ 1,962 Loans collectively evaluated for impairment 8,661 — 4,453 166 1,885 — 15,165 Total $ 10,623 $ — $ 4,453 $ 166 $ 1,885 $ — $ 17,127 Loan balance at March 31, 2021 related to: Loans individually evaluated for impairment $ 20,452 $ — $ 5,389 $ — $ — $ — $ 25,841 Loans collectively evaluated for impairment 300,867 280,562 538,486 11,840 86,754 — 1,218,509 Total $ 321,319 $ 280,562 $ 543,875 $ 11,840 $ 86,754 $ — $ 1,244,350 ALLL balance at December 31, 2020 related to: Loans individually evaluated for impairment $ 2,711 $ — $ — $ — $ — $ — $ 2,711 Loans collectively evaluated for impairment 8,544 — 3,964 137 2,096 — 14,741 Total $ 11,255 $ — $ 3,964 $ 137 $ 2,096 $ — $ 17,452 Loan balance at December 31, 2020 related to: Loans individually evaluated for impairment $ 30,886 $ — $ 6,661 $ — $ — $ — $ 37,547 Loans collectively evaluated for impairment 306,541 229,728 544,751 11,766 93,525 — 1,186,310 Total $ 337,427 $ 229,728 $ 551,412 $ 11,766 $ 93,525 $ — $ 1,223,857 Credit Quality The amounts of nonperforming assets and delinquencies that occur within our loan portfolio factor into our evaluation of the adequacy of the ALLL. The following table provides a summary of the delinquency status of loans by portfolio type at March 31, 2021 and December 31, 2020: 30-59 Days Past Due 60-89 Days Past Due 90 Days and Greater Total Past Due Current Total Loans Outstanding Loans >90 Days and Accruing (Dollars in thousands) At March 31, 2021 Commercial loans, excluding PPP $ 1,367 $ 80 $ 578 $ 2,025 $ 319,294 $ 321,319 $ — Commercial loans - PPP — — — — 280,562 280,562 — Commercial real estate loans – owner-occupied — — — — 189,203 189,203 — Commercial real estate loans – — — — — 197,026 197,026 — Residential mortgage loans – — — — — 157,646 157,646 — Residential mortgage loans – — — — — 10,085 10,085 — Construction and land development loans — — — — 11,840 11,840 — Consumer loans 89 13 45 147 76,522 76,669 — Total $ 1,456 $ 93 $ 623 $ 2,172 $ 1,242,178 $ 1,244,350 $ — At December 31, 2020 Commercial loans, excluding PPP $ 5,281 $ 3,646 $ 9,670 $ 18,597 $ 318,830 $ 337,427 $ 5,675 Commercial loans - PPP — — — — 229,728 229,728 — Commercial real estate loans – owner-occupied — — — — 197,336 197,336 — Commercial real estate loans – — — 1,837 1,837 193,056 194,893 — Residential mortgage loans – — — — — 159,182 159,182 — Residential mortgage loans – — — — — 12,766 12,766 — Construction and land development loans — — — — 11,766 11,766 — Consumer loans — 65 — 65 80,694 80,759 — Total $ 5,281 $ 3,711 $ 11,507 $ 20,499 $ 1,203,358 $ 1,223,857 $ 5,675 Generally, the accrual of interest on a loan is discontinued when principal or interest payments become more than 90 days past due, unless we believe that the loan is adequately collateralized and it is in the process of collection. There were no loans 90 days or more past due and still accruing interest at March 31, 2021, and $5.7 million loans 90 days or more past due and still accruing interest at December 31, 2020. In certain instances, when a loan is placed on nonaccrual status, previously accrued but unpaid interest is reversed against current income. Subsequent collections of cash are applied as principal reductions when received (referred to as full nonaccrual basis of accounting), except when the ultimate collectability of principal is probable, in which case such payments are applied to accrued and unpaid interest, which is credited to income (referred to as nonaccrual cash basis of accounting). Nonaccrual loans may be restored to accrual status when principal and interest become current and full repayment becomes expected. The following table provides information with respect to loans on nonaccrual status, by portfolio type, as of March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 (Dollars in thousands) Nonaccrual loans: Commercial loans $ 19,426 $ 30,928 Commercial real estate loans – owner occupied 952 6,978 Commercial real estate loans – all other — 1,836 Consumer 181 174 Total (1) $ 20,559 $ 39,916 (1) Nonaccrual loans may include loans that are currently considered performing loans. We classify our loan portfolio using internal asset quality ratings. The following table provides a summary of loans by portfolio type and our internal asset quality ratings as of March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 (Dollars in thousands) Pass: Commercial loans, excluding PPP $ 271,240 $ 263,616 Commercial loans - PPP 280,562 229,728 Commercial real estate loans – owner occupied 167,057 162,250 Commercial real estate loans – all other 196,243 192,264 Residential mortgage loans – multi family 156,678 158,816 Residential mortgage loans – single family 10,085 12,766 Construction and land development loans 11,340 11,766 Consumer loans 76,481 80,576 Total pass loans $ 1,169,686 $ 1,111,782 Special Mention: Commercial loans $ 10,667 $ 13,763 Commercial real estate loans – owner occupied — 6,882 Commercial real estate loans – all other — 793 Residential mortgage loans – multi family 969 366 Total special mention loans $ 11,636 $ 21,804 Substandard: Commercial loans $ 39,305 $ 59,408 Commercial real estate loans – owner occupied 22,145 28,203 Commercial real estate loans – all other 783 1,837 Construction and land development loans 500 — Consumer loans 188 182 Total substandard loans $ 62,921 $ 89,630 Doubtful: Commercial loans $ 107 $ 641 Total doubtful loans $ 107 $ 641 Total Loans: $ 1,244,350 $ 1,223,857 Impaired Loans A loan generally is classified as impaired when, in our opinion, principal or interest is not likely to be collected in accordance with the contractual terms of the loan agreement. We measure for impairments on a loan-by-loan basis, using either the present value of expected future cash flows discounted at the loan’s effective interest rate, or the fair value of the collateral if the loan is collateral dependent. The following table sets forth information regarding impaired loans, at March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 (Dollars in thousands) Impaired loans: Nonaccruing loans $ 17,064 $ 33,204 Nonaccruing restructured loans 3,495 6,712 Accruing restructured loans (1) 5,589 — Total impaired loans $ 26,148 $ 39,916 Impaired loans less than 90 days delinquent and included in total impaired loans $ 25,525 $ 34,085 (1) See “ Troubled Debt Restructurings ” below for a description of accruing restructured loans at March 31, 2021 and December 31, 2020. The table below contains additional information with respect to impaired loans, by portfolio type, as of March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 Recorded Investment Unpaid Principal Balance Related Allowance (1) Recorded Investment Unpaid Principal Balance Related Allowance (1) (Dollars in thousands) No allowance recorded: Commercial loans, excluding PPP $ 5,627 $ 11,935 $ — $ 10,970 $ 19,530 $ — Commercial real estate loans – owner occupied 5,479 6,198 — 6,978 7,633 — Commercial real estate loans – all other — — — 1,836 1,837 — Consumer loans 181 222 — 174 197 — Total $ 11,287 $ 18,355 $ — $ 19,958 $ 29,197 $ — With allowance recorded: Commercial loans, excluding PPP $ 14,861 $ 15,041 $ 1,962 $ 19,958 $ 20,040 $ 2,711 Total $ 14,861 $ 15,041 $ 1,962 $ 19,958 $ 20,040 $ 2,711 All impaired loans Commercial loans, excluding PPP $ 20,488 $ 26,976 $ 1,962 $ 30,928 $ 39,570 $ 2,711 Commercial real estate loans – owner occupied 5,479 6,198 — 6,978 7,633 — Commercial real estate loans – all other — — — 1,836 1,837 — Consumer loans 181 222 — 174 197 — Total $ 26,148 $ 33,396 $ 1,962 $ 39,916 $ 49,237 $ 2,711 (1) When the discounted cash flows, collateral value or market price equals or exceeds the recorded investment in the loan, then specific reserves are not required to be set aside for the loan within the ALLL. This typically occurs when the impaired loans have been partially charged-off and/or there have been interest payments received and applied to the balance of the principal outstanding. At March 31, 2021 and December 31, 2020, there were $11.3 million and $20.0 million, respectively, of impaired loans for which no specific reserves had been allocated because these loans, in our judgment, were sufficiently collateralized. Of the impaired loans at March 31, 2021 for which no specific reserves were allocated, $8.6 million had been deemed impaired in the prior year. Average balances and interest income recognized on impaired loans, by portfolio type, for the three months ended March 31, 2021 and 2020 were as follows: Three Months Ended March 31, 2021 2020 Average Balance Interest Income Recognized Average Balance Interest Income Recognized (Dollars in thousands) No allowance recorded: Commercial loans, excluding PPP $ 8,298 $ 54 $ 10,178 $ — Commercial real estate loans – owner occupied 6,228 — 6,438 — Commercial real estate loans – all other 918 — — — Consumer loans 178 — 130 — Total 15,622 54 16,746 — With allowance recorded: Commercial loans, excluding PPP 17,410 1,105 — Total 17,410 — 1,105 — Total Commercial loans, excluding PPP 25,708 54 11,283 — Commercial real estate loans – owner occupied 6,228 — 6,438 — Commercial real estate loans – all other 918 — — — Consumer loans 178 — 130 — Total $ 33,032 $ 54 $ 17,851 $ — The interest that would have been earned had the impaired loans remained current in accordance with their original terms was $424 thousand and $574 thousand during the three months ended March 31, 2021 and 2020, respectively. Troubled Debt Restructurings (“TDRs”) Pursuant to the FASB's ASU No. 2011-2, A Creditor’s Determination of whether a Restructuring is a Troubled Debt Restructuring , the Bank's TDRs totaled $9.1 million at March 31, 2021. There were $6.7 million TDRs as of December 31, 2020. TDRs consist of loans to which modifications have been made for the purpose of alleviating temporary impairments of the borrower's financial condition and cash flows. Those modifications have come in the form of changes in amortization terms, reductions in interest rates, interest only payments and, in limited cases, concessions to outstanding loan balances. The modifications are made as part of workout plans we enter into with the borrower that are designed to provide a bridge for the borrower’s cash flow shortfalls in the near term. If a borrower works through the near term issues, then in most cases, the original contractual terms of the borrower’s loan will be reinstated. TDRs do not include short term loan modifications made on a good faith basis in response to COVID-19, per Section 4013, Temporary Relief from Troubled Debt Restructurings , of the CARES Act. There were no loans restructured as TDRs during the three months ended March 31, 2020. The following table presents loans restructured as TDRs during the three months ended March 31, 2021 and 2020: Three Months Ended March 31, 2021 March 31, 2020 (Dollars in thousands) Number of Pre-Modification Post-Modification Number of Pre-Modification Post-Modification Performing Commercial loans 2 $ 2,639 $ 1,062 — $ — $ — Commercial real estate – owner occupied 1 4,929 4,527 — — — 3 7,568 5,589 — — — Nonperforming Commercial loans 5 $ 5,266 $ 3,495 — $ — $ — 5 5,266 3,495 — — — Total Troubled Debt Restructurings (1) 8 $ 12,834 $ 9,084 — $ — $ — (1) No outstanding loans were restructured during the three months ended March 31, 2020.

Leases

Leases	3 Months Ended
	Mar. 31, 2021
Leases [Abstract]
Leases	Leases We have historically entered into a number of lease arrangements under which we are the lessee. Specifically, all of our physical locations are subject to operating leases. In addition, we have elected the short-term lease practical expedient related to operating leases. Two of our office leases, including our corporate headquarters, include multiple optional renewal periods. To the extent we conclude that it is reasonably certain that a renewal option will be exercised, that renewal period is then included in the lease term, and the related payments are reflected in the ROU asset and lease liability. We did not consider any additional renewal periods to be reasonably certain of being exercised for our corporate headquarters because of the length of the lease term to renewal. All of our leases include fixed rental payments. We commonly enter into leases under which the lease payments increase at predetermined dates. While the majority of our leases are gross leases, we also have a number of leases in which we make separate payments to the lessor based on the lessor’s property and casualty insurance costs and the property taxes assessed on the property, as well as a portion of the common area maintenance associated with the property. During the three months ended March 31, 2021 and 2020, we recognized rent expense associated with our leases as follows: Three Months Ended March 31, 2021 2020 Lease cost (Dollars in thousands) Finance lease cost: Operating lease cost $ 605 $ 609 Short-term lease cost (1) 37 35 Total lease cost $ 642 $ 644 Weighted-average remaining lease term—operating leases (in years) 4.12 5.12 (1) Includes leases that are less than 12 months and equipment leases that are accounted for on a cash basis. Because we generally do not have access to the rate implicit in the lease, we utilize our borrowing rate with the FHLB as the discount rate. The weighted average discount rate associated with operating leases as of March 31, 2021 and 2020 is 2.31% and 2.31%, respectively. Supplemental balance sheet information related to leases was as follows: Financial Statement Classification March 31, 2021 December 31, 2020 (Dollars in thousands) Operating right-of-use assets Other assets $ 9,457 $ 10,002 Operating lease liabilities Other liabilities $ 10,383 $ 10,933 During the three months ended March 31, 2021 and 2020 , we had the following cash and noncash activities associated with our leases: Three Months Ended March 31, Three Months Ended March 31, 2021 2020 (Dollars in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases (fixed payments) $ 610 $ 572 Noncash activities: Right-of-use assets obtained in exchange for new operating lease liabilities $ — $ — Maturities of operating lease liabilities as of March 31, 2021 are as follows: (Dollars in thousands) For the years ending December 31, Remainder of 2021 $ 1,879 2022 2,575 2023 2,662 2024 2,750 2025 1,021 2025 and beyond — Total 10,887 Less: Imputed interest (504) Total Lease liabilities $ 10,383

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2021
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes For the three months ended March 31, 2021, we had income tax expense of $1.4 million as a result of our operating income. Accounting rules specify that management must evaluate the deferred tax asset on a recurring basis to determine whether enough positive evidence exists to determine whether it is more-likely-than-not that the deferred tax asset will be available to offset or reduce future taxes. The tax code allows net operating losses incurred prior to December 31, 2017 to be carried forward for 20 years from the date of the loss, and based on its evaluation, management believes that the Company will be able to realize the deferred tax asset within the period that our net operating losses may be carried forward. Due to the hierarchy of evidence that the accounting rules specify, management determined that there continued to be enough positive evidence to support no valuation allowance on our deferred tax asset at March 31, 2021. Significant positive evidence included our three-year cumulative income position, the expectation that we will have positive earnings for the year based on positive income in eleven of the last twelve trailing quarters, forecasted net income for the year, and retained earnings. Negative evidence included our asset quality which has improved since the prior quarter. For the three months ended March 31, 2020, we had an income tax benefit of $991 thousand, as a result of our operating loss. During the three months ended March 31, 2020, management determined that there continued to be enough positive evidence to support no valuation allowance on our deferred tax asset. Based on this evaluation, management believed that the Company would be able to realize the deferred tax asset within the period that our operating losses may be carried forward. Significant positive evidence included our three-year cumulative income position, the expectation that we will continue to have positive earnings based on positive income in eleven of the last twelve trailing quarters, and forecasted net income for the year. Negative evidence at March 31, 2020 included our accumulated deficit, net loss for the quarter, and deterioration in asset quality. We file income tax returns with the U.S. federal government and the State of California. As of March 31, 2021, we were subject to examination by the Internal Revenue Service with respect to our U.S. federal tax returns for the 2017 to 2020 tax years and the Franchise Tax Board for California state income tax returns for the 2016 to 2020 tax years. Net operating losses on our U.S. federal and California state income tax returns may be carried forward up to 20 years. In June 2020, the State of California suspended the use of net operating losses for the years 2020, 2021, and 2022, and extended the carryover periods for these years. As of March 31, 2021, we do not have any unrecognized tax benefits.

Stock-Based Employee Compensati

Stock-Based Employee Compensation Plans	3 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Stock-Based Employee Compensation Plans	Stock-Based Employee Compensation Plans In May 2010, our shareholders approved the adoption of our 2010 Equity Incentive Plan, which was amended at the Annual Shareholders meeting held in May 2013 (the “2010 Incentive Plan”), and which superseded our shareholder-approved 2008 and 2004 Equity Incentive Plans (the “Previously Approved Plans”). As of March 31, 2021, there were no options to purchase shares of our common stock granted under the Previously Approved Plans. As of March 31, 2021, there were options to purchase a total of 323,587 shares of our common stock and 35,353 shares of our unvested restricted stock grants under the 2010 Incentive Plan. In May 2019, our shareholders approved the adoption of our 2019 Equity Incentive Plan (the “2019 Incentive Plan”), which authorized and set aside a total of 2,000,000 shares of our common stock for issuance on the exercise of stock options or the grant of restricted stock or other equity incentives to our officers, and other key employees and directors. Since approval of the 2019 Incentive Plan, no additional awards will be issued under the 2010 Incentive Plan, although awards outstanding under the 2010 Incentive Plan will remain outstanding and will continue to be governed by the terms of the 2010 Incentive Plan and any applicable award agreements. Under the terms of the 2019 Incentive Plan, any forfeited options or unvested restricted stock grants that had been issued under the Previously Approved Plans or the 2010 Incentive Plan will not be available for future equity incentive grants. Each restricted stock option or restricted stock unit issued under the terms of the 2019 Incentive Plan will be counted against the share limit as 2.5 shares, while each stock option or SAR issued will be counted as one share against the share limit. As of March 31, 2021, there were outstanding options to purchase a total of 250,000 shares of our common stock, 75,000 shares of our unvested restricted stock units, and 158,894 shares of our unvested restricted stock grants under the 2019 Incentive Plan. As of March 31, 2021, there remain 1,039,830 shares available for future grants under the 2019 Incentive Plan. A stock option entitles the recipient to purchase shares of our common stock at a price per share that may not be less than 100% of the fair market value of the Company’s shares on the date the option is granted. Restricted shares may be granted at such purchase prices and on such other terms, including restrictions and Company repurchase or reacquisition rights, as are fixed by the Compensation Committee at the time rights to purchase such restricted shares are granted. Stock Appreciation Rights (“SARs”) entitle the recipient to receive a cash payment in an amount equal to the difference between the fair market value of the Company’s shares on the date of vesting and a “base price” (which, in most cases, will be equal to the fair market value of the Company’s shares on the date the SAR is granted), subject to the right of the Company to make such payment in shares of its common stock at their then fair market value. Stock units may be payable in cash or shares of common stock, or a combination of the two. A stock unit is a bookkeeping entry representing the equivalent of one common share. Options, restricted shares, SARs and stock units may vest immediately or in installments over various periods generally ranging up to five years, subject to the recipient’s continued employment or service or the achievement of specified performance goals, as determined by the Compensation Committee at the time it grants or awards the options, the restricted shares, the SARs or the stock units. Stock options, SARs and stock units may be granted for terms of up to 10 years after the date of grant, but will terminate sooner upon or shortly after a termination of service occurring prior to the expiration of the term of the option, SAR or stock unit. The Company will become entitled to repurchase any unvested restricted shares, at the same price that was paid for the shares by the recipient, or to cancel those shares in the event of a termination of employment or service of the holder of such shares or if any performance goals specified in the award are not satisfied. To date, the Company has not granted any SARs. Under FASB ASC 718-10, we are required to recognize, in our financial statements, the fair value of the options, restricted shares, SARs and stock units that we grant as compensation cost over their respective service periods. The fair values of the options that were outstanding at March 31, 2021 under the 2010 Incentive Plan and the 2019 Incentive Plan were estimated as of their respective dates of grant using the Black-Scholes option-pricing model. The Company, under the 2010 Incentive Plan and the 2019 Incentive Plan, has also granted restricted stock and stock units for the benefit of its employees and directors. These restricted shares vest over a period ranging from three one Stock Options There were no stock options granted during the three months ended March 31, 2021 or 2020. The following table summarizes the stock option activity under the Company’s equity incentive plans during the three months ended March 31, 2021 and 2020, respectively. Number of Weighted- Number of Weighted- 2021 2020 Outstanding – January 1, 589,587 $ 7.01 1,009,466 $ 6.98 Granted — — — — Exercised (16,000) 4.34 (10,728) 4.66 Forfeited/Canceled — — (360,078) 6.92 Outstanding – March 31, 573,587 7.09 638,660 7.05 Options Exercisable – March 31, 361,545 $ 6.93 344,581 $ 6.74 Options Vested – March 31, 361,545 $ 6.93 344,581 $ 6.74 Options to purchase 16,000 and 10,728 shares of our common stock were exercised during the three months ended March 31, 2021 and 2020, respectively. The aggregate intrinsic value of options exercised during the three months ended March 31, 2021 and 2020 was $38 thousand and $29 thousand, respectively. The fair value of options that vested during the three months ended March 31, 2021 and 2020 was $59 thousand and $83 thousand, respectively. The following table provides additional information regarding the vested and unvested options that were outstanding at March 31, 2021. Options Outstanding as of March 31, 2021 Options Exercisable as of March 31, 2021 (1) Exercise Price Vested Unvested Weighted Weighted Shares Weighted $2.97 – $3.99 12,000 — $ 3.74 0.82 12,000 $ 3.74 $4.00 – $5.99 — — — — — — $6.00 – $6.99 202,189 5,450 6.61 3.87 202,189 6.60 $7.00 – $7.99 84,157 200,000 7.30 7.88 84,157 7.24 $8.00 – $8.40 63,199 6,592 8.21 6.90 63,199 8.19 361,545 212,042 $ 7.09 6.16 361,545 $ 6.93 (1) The weighted average remaining contractual life of the options that were exercisable as of March 31, 2021 was 4.91 years. The aggregate intrinsic value of options that were outstanding and exercisable at March 31, 2021 and December 31, 2020 was $713 thousand and $30 thousand, respectively. A summary of the status of the unvested options outstanding as of March 31, 2021 and 2020, and changes in the weighted average grant date fair values of the unvested options during the three months ended March 31, 2021 and 2020, are set forth in the following table. For the three months ended March 31, 2021 2020 Number of Weighted Number of Weighted Unvested at the beginning of the period 233,107 $ 2.10 334,322 $ 2.19 Granted — — — — Vested (21,065) 2.81 (29,409) 2.81 Forfeited/Canceled — — (10,834) 2.82 Unvested at the end of the period 212,042 2.03 294,079 2.11 At March 31, 2021, the weighted average period over which nonvested awards were expected to be recognized was 3.32 years. Restricted Stock The following table summarizes the activity related to restricted stock granted, vested and forfeited under our equity incentive plans during the three months ended March 31, 2021 and 2020. For the three months ended March 31, 2021 2020 Number of Shares Average Grant Date Fair Value Per Share Number of Shares Average Grant Date Fair Value Per Share Outstanding at the beginning of the period 123,165 $ 6.63 124,202 $ 8.44 Granted 112,970 6.68 37,739 6.99 Vested (41,888) 7.71 (39,889) 8.59 Forfeited — — (18,357) 8.25 Outstanding at the end of the period 194,247 $ 6.43 103,695 $ 7.90 Stock Units The following table summarizes the activity related to stock units granted, vested and forfeited under our equity incentive plans during the three months ended March 31, 2021 and 2020. For the three months ended March 31, 2021 2020 Number of Shares Average Grant Date Fair Value Per Share Number of Shares Average Grant Date Fair Value Per Share Outstanding at January 1, 75,000 $ 7.33 100,000 $ 7.33 Granted — — — — Vested — — — — Forfeited — — — — Outstanding at March 31, 75,000 $ 7.33 100,000 $ 7.33 Compensation Expense We expect that the compensation expense that will be recognized during the periods presented below in respect to stock options, restricted stock, and stock units outstanding at March 31, 2021, will be as follows: Estimated Stock Based Compensation Expense Stock Options Estimated Stock Based Compensation Expense Restricted Stock Estimated Stock Based Compensation Expense Stock Units Estimated Stock Based Compensation Expense Total (Dollars in thousands) For the years ending December 31, Remainder of 2021 $ 85 $ 448 $ 184 $ 717 2022 109 346 164 619 2023 101 260 — 361 2024 67 48 — 115 2024 and beyond — 10 — 10 $ 362 $ 1,112 $ 348 $ 1,822

Earnings Per Share ("EPS")

Earnings Per Share ("EPS")	3 Months Ended
	Mar. 31, 2021
Earnings Per Share [Abstract]
Earnings Per Share ("EPS")	Earnings Per Share (“EPS”) Basic EPS excludes dilution and is computed by dividing net income or loss allocable to common shareholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if stock options or other contracts to issue common stock were exercised or converted into common stock that would then share in our earnings. The following table shows how we computed basic and diluted EPS for the three months ended March 31, 2021 and 2020. (In thousands, except per share data) For the Three Months Ended March 31, 2021 2020 Basic EPS: Net income (loss) $ 3,388 $ (2,361) Net income (loss) allocable to common shareholders $ 3,388 $ (2,361) Less earnings allocated to participating securities 33 — Earnings (loss) allocated to common shareholders $ 3,355 $ (2,361) Weighted average common shares outstanding 23,562 23,475 Basic earnings (loss) per common share $ 0.14 $ (0.10) Diluted EPS: Earnings (loss) allocated to common shareholders $ 3,388 $ (2,361) Weighted average common shares outstanding 23,562 23,475 Add dilutive effects of restricted stock grants 158 — Add dilutive effects of restricted stock units 75 — Add dilutive effects for stock options 18 — Weighted average diluted common shares outstanding 23,813 23,475 Diluted earnings (loss) per common share $ 0.14 $ (0.10) (1) The basic and diluted earnings per share amounts for the three months ended March 31, 2021 and 2020 are the same under both the Treasury Stock Method and the Two-Class Method as prescribed in FASB ASC 260-10, Earnings Per Share . The weighted average shares that have an antidilutive effect in the calculation of diluted net income per share and have been excluded from the computations above were as follows: For the Three Months Ended March 31, 2021 2020 Stock options (1)(2) 377,198 800,960 (1) Stock options that were excluded from the computation of diluted earnings per common share for the three months ended March 31, 2021 and 2020 as a result of the reported net loss available to common shareholders.

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Shareholders' Equity	Shareholders’ Equity Accumulated Other Comprehensive Income (Loss), net Accumulated other comprehensive income (loss), net as of March 31, 2021 and December 31, 2020 was as follows: Unrealized Gain (Loss) on Securities Available-for-Sale, net of tax Accumulated Other Comprehensive Income (Loss), Net (Dollars in thousands) Beginning balance as of January 1, 2019 $ (1,144) $ (1,144) Other comprehensive loss, net of tax of $62 thousand 577 577 Ending balance as of December 31, 2019 $ (567) $ (567) Other comprehensive income, net of tax of $202 thousand 483 483 Ending balance as of December 31, 2020 $ (84) $ (84) Other comprehensive income, net of tax of $487 thousand (1,161) (1,161) Ending balance as of March 31, 2021 $ (1,245) $ (1,245)

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Commitments To meet the financing needs of our customers in the normal course of business, we are a party to financial instruments with off-balance sheet risk. These financial instruments include commitments to extend credit and standby letters of credit. These instruments involve, to varying degrees, elements of credit and interest rate risk in excess of the amount recognized in the consolidated financial statements. At March 31, 2021 and December 31, 2020, we were committed to fund certain loans including letters of credit amounting to approximately $341 million and $347 million, respectively. The contractual amounts of a credit-related financial instrument, such as a commitment to extend credit, a credit-card arrangement or a letter of credit, represent the amount of potential accounting loss should the commitment be fully drawn upon, the customer were to default, and the value of any existing collateral securing the customer’s payment obligation becomes worthless. The loss reserve for unfunded loan commitments was $350 thousand at both March 31, 2021 and December 31, 2020. As a result, we use the same credit policies in making commitments to extend credit and conditional obligations as we do for on-balance sheet instruments. Commitments generally have fixed expiration dates; however, since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. We evaluate each customer’s creditworthiness on a case-by-case basis, using the same credit underwriting standards that are employed in making commercial loans. The amount of collateral obtained, if any, upon an extension of credit is based on our evaluation of the creditworthiness of the customer. Collateral held varies, but may include accounts receivable, inventory, property, plant and equipment, residential real estate and income-producing commercial properties. Borrowings At March 31, 2021 and December 31, 2020, our borrowings and contractual obligations consisted of the following: (Dollars in thousands) March 31, 2021 December 31, 2020 FHLB advances—short-term $ — $ 10,000 Total $ — $ 10,000 At March 31, 2021, $439 million of loans were pledged to support our FHLB borrowings and our unfunded borrowing capacity. As of March 31, 2021, we had unused borrowing capacity of $286 million with the FHLB. The highest amount of borrowings outstanding at any month-end during the three months ended March 31, 2021 was $10.0 million. At March 31, 2021 and December 31, 2020, commercial and consumer loans of $130 million and $146 million, respectively, were pledged to secure borrowings from the FRB to support our unfunded borrowing capacity of $94 million and $106 million, respectively. As of December 31, 2020, we had $10.0 million of outstanding short-term borrowings and no outstanding long-term borrowings that we had obtained from the FHLB. These borrowings had a weighted-average annualized interest rate of 1.62% for the year ended December 31, 2020. As of December 31, 2020, we had unused borrowing capacity of $242 million with the FHLB. The highest amount of borrowings outstanding at any month-end during the year ended December 31, 2020 was $124 million. Litigation, Claims and Assessments We are a defendant in or a party to a number of legal actions or proceedings that arise in the ordinary course of business. In some of these actions and proceedings, claims for monetary damages are asserted against us. In accordance with applicable accounting guidance, we establish an accrued liability for lawsuits or other legal proceedings when they present loss contingencies that are both probable and estimable. We estimate any potential loss based upon currently available information and significant judgments and a variety of assumptions, and known and unknown uncertainties. Moreover, the facts and circumstances on which such estimates are based will change over time. Therefore, the amount of any losses we might incur in any lawsuits or other legal proceedings may exceed amounts which we had accrued based on our estimates and those estimates do not represent the maximum loss exposure that we may have in connection with any lawsuits or other legal proceedings. Based on our evaluation of lawsuits and other proceedings that were pending against us as of March 31, 2021, the outcomes in those suits or other proceedings are not expected to have, either individually or in the aggregate, a material adverse effect on our consolidated financial position, results of operations or cash flows. However, in light of the inherent uncertainties involved, some of which are beyond our control, and the very large or indeterminate damages often sought in such legal actions or proceedings, an adverse outcome in one or more of these suits or proceedings could be material to our results of operations or cash flows for any particular reporting period.

Business Segment Information

Business Segment Information	3 Months Ended
	Mar. 31, 2021
Segment Reporting [Abstract]
Business Segment Information	Business Segment Information We have one reportable business segment, commercial banking. The commercial banking segment provides middle-market businesses, professional firms and individuals with a diversified range of products and services such as various types of deposit accounts, various types of commercial and consumer loans, cash management services, and online banking services. Since our operating segment derives all of its revenues from interest and noninterest income and interest expense constitutes its most significant expense, this segment is reported below using net interest income (interest income less interest expense) and noninterest income (primarily net gains on sales of Small Business Administration loans and fee income). We do not allocate general and administrative expenses or income taxes to our operating segment. The following table sets forth information regarding the net interest income and noninterest income for our commercial banking segment for the three months ended March 31, 2021 and 2020. (Dollars in thousands) Commercial Other (1) Total Net interest income for the three months ended March 31, 2021 $ 12,861 $ (122) $ 12,739 2020 $ 11,670 $ (197) $ 11,473 Noninterest income for the three months ended March 31, 2021 $ 1,734 $ 4 $ 1,738 2020 $ 1,089 $ 6 $ 1,095 Segment Assets at: March 31, 2021 $ 1,579,123 $ 914 $ 1,580,037 December 31, 2020 $ 1,586,916 $ 674 $ 1,587,590 (1) Represents net interest income (loss) and noninterest income for PMBC.

Regulatory Capital

Regulatory Capital	3 Months Ended
	Mar. 31, 2021
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]
Regulatory Capital	Regulatory Capital Under federal banking regulations that apply to all United States-based bank holding companies over $3 billion in total assets and all federally insured banks, the Bank (on a stand-alone basis) must meet specific capital adequacy requirements that, for the most part, involve quantitative measures, primarily in terms of the ratios of their capital to their assets, liabilities, and certain off-balance sheet items, calculated under regulatory accounting practices. The Company (on a consolidated basis) is below the reporting threshold of $3 billion in total assets and therefore is not subject to the same capital adequacy requirements. Under those regulations, each federally insured bank is determined by its primary federal bank regulatory agency to come within one of the following capital adequacy categories on the basis of its capital ratios: • well-capitalized • adequately capitalized • undercapitalized • significantly undercapitalized; or • critically undercapitalized Certain qualitative assessments also are made by a banking institution’s primary federal regulatory agency that could lead the agency to determine that the banking institution should be assigned to a lower capital category than the one indicated by the quantitative measures used to assess the institution’s capital adequacy. At each successive lower capital category, a banking institution is subject to greater operating restrictions and increased regulatory supervision by its federal bank regulatory agency. The following table sets forth the capital and capital ratios of the Bank (on a stand-alone basis) at March 31, 2021, as compared to the regulatory requirements applicable to it. Applicable Federal Regulatory Requirement For Capital To be Categorized As Amount Ratio Amount Ratio Amount Ratio (Dollars in thousands) Total Capital to Risk Weighted Assets $ 187,050 16.8 % $ 133,331 At least 8.625 $ 111,678 At least 10.0 Common Equity Tier 1 Capital to Risk Weighted Assets $ 173,047 15.5 % $ 57,235 At least 5.125 $ 72,591 At least 6.5 Tier 1 Capital to Risk Weighted Assets $ 173,047 15.5 % $ 73,987 At least 6.625 $ 89,343 At least 8.0 Tier 1 Capital to Average Assets $ 173,047 11.2 % $ 61,835 At least 4.0 $ 77,294 At least 5.0 In early July 2013, the Federal Reserve Board and the FDIC issued final rules implementing the Basel III regulatory capital framework and related Dodd-Frank Wall Street Reform and Consumer Protection Act changes. The rules revise minimum capital requirements and adjust prompt correct action thresholds. The final rules revise the regulatory capital elements, add a new common equity Tier 1 capital ratio, increase the minimum Tier 1 capital ratio requirement, and implement a new capital conservation buffer. The rules also permit certain banking organizations to retain, through a one-time election, the existing treatment for accumulated other comprehensive income. The final rules took effect for community banks on January 1, 2015, subject to a transition period for certain parts of the rules. At March 31, 2021, the Bank (on a stand-alone basis) continued to qualify as a well-capitalized institution under the capital adequacy guidelines described above.

Risk and Uncertainties

Risk and Uncertainties	3 Months Ended
	Mar. 31, 2021
Risks and Uncertainties [Abstract]
Risks and Uncertainties	Risks and Uncertainties The outbreak of the novel coronavirus (“COVID-19”) and the Federal Reserve's response to the economic challenges has resulted in an uncertain and rapidly evolving economy. Governmental response to combat this pandemic has resulted in approximately 25% of our staff to shift to work remotely. Our business continuity plans have been activated by COVID-19 and we have been able to fully support our remote workforce and have the ability to support all employees in a remote work environment. These remote work arrangements have not adversely impacted our ability to serve our clients, and have not had an impact on our financial reporting systems or the internal controls we have over financial reporting, disclosures and related procedures. The most significant impact of COVID-19 on our business has been to the quality of our loan portfolio and to net interest income as short-term interest rates sharply declined. We have increased the qualitative factors used in the determination of the adequacy of our allowance for loan and lease loss in anticipation of the impact that COVID-19 will have on our clients and their ability to fulfill their obligations. We have no certainty that the provisions we made during 2020 will be sufficient to absorb the losses that stem from the impact of COVID-19 on our clients. As the longer term effects on our clients from the COVID-19 pandemic become more apparent, we may need to charge-off some or all of the balance on certain loans and make further provisions to increase our allowance for loan and lease losses. These potential additional provisions for loan and lease losses will have a direct impact upon our capital, including the potential need to reevaluate the need for a valuation allowance on our deferred tax asset. At this time, we don't expect that there would be any material impairment to the valuation of other long-lived assets, right of use assets, or our investment securities. The Bank is currently Well Capitalized under federal banking regulations that apply to all United States-based banks, with approximately $75 million of capital in excess of what is required for the Bank to be Well Capitalized using the ratio of Total Capital to Risk Weighted Assets. The Company has approximately $10 million of capital that it could contribute to the Bank should it be needed. In the event that future loan and leases loss and/or tax provisions reduce our capital surplus, we would be required to undertake measures to return the Bank's capital ratios to Well Capitalized levels, which could include but not be limited to raising additional capital or reducing the Bank's asset size. We believe that we would have access to equity and debt markets to secure additional capital for the Bank should the need arise, but we have no certainty regarding the extent of the availability of these markets at the time such need would arise. Increased demand for liquidity by our clients is another impact that we anticipate could occur should the COVID-19 effects be prolonged. As of March 31, 2021, we believe the Company and the Bank's on-balance sheet liquidity was very strong. Combined with our contingent liquidity resources, we believe that the Bank has sufficient resources to meet the liquidity needs of our clients. In response to COVID-19, the Federal Reserve has made other provisions that could assist the Bank in satisfying its liquidity needs, such as reducing our reserve requirement to zero, expanding access to the discount window through collateral pledging and extension of term borrowings.

Significant Accounting Polici_2

Significant Accounting Policies - (Policies)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Interim Consolidated Financial Statements Basis of Presentation	Interim Consolidated Financial Statements Basis of PresentationOur interim consolidated financial statements are prepared in accordance with generally accepted accounting principles in effect in the United States (“GAAP”) for interim financial information pursuant to rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”), including instructions to Form 10-Q and Article 10 of Regulation S-X, on a basis consistent with prior periods. Our financial statements reflect all adjustments that are, in the opinion of management, necessary to present a fair statement of the results for the interim periods presented. All such adjustments were of a normal and recurring nature. The interim results are not necessarily indicative of operating results for the full year. The interim information should be read in conjunction with our audited consolidated financial statements in our Form 10-K.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires us to make certain estimates and assumptions that could affect the reported amounts of certain of our assets, liabilities, and contingencies at the date of the financial statements and the reported amounts of our revenues and expenses during the reporting periods. For the fiscal periods covered by this report, those estimates related primarily to our determinations of the allowance for loan and lease losses (“ALLL”), the fair values of securities available for sale, and the determination of the valuation allowance pertaining to deferred tax assets. If circumstances or financial trends on which those estimates were based were to change in the future or there were to occur any currently unanticipated events affecting the amounts of those estimates, our future financial position or results of operations could differ, possibly materially, from those expected at the current time.
Principles of Consolidation	Principles of ConsolidationOur consolidated financial statements as of March 31, 2021 and December 31, 2020 and for the three months ended March 31, 2021 and 2020 include the accounts of PMBC and the Bank. All significant intercompany balances and transactions were eliminated in consolidation.
Recent Accounting Pronouncements	Recent Accounting Pronouncements In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2016-13, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which requires the measurement of all expected credit losses for financial assets held at the reporting date, based on historical experience, current conditions, and reasonable and supportable forecasts. Financial institutions will now use forward-looking information to better inform their credit loss estimates. Additionally, the ASU amends the accounting guidance for credit losses on available-for-sale debt securities and purchased financial assets with credit deterioration. On November 15, 2019, the FASB issued ASU 2019-10, "Financial Instruments—Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842): Effective Dates " which finalizes various effective date delays for private companies, not-for-profit organizations, and smaller reporting companies applying the credit losses (CECL), leases, and hedging standards. The effective date for smaller reporting companies has been delayed from the interim and annual periods beginning after December 15, 2020 to the interim and annual periods beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning after December 15, 2018. We plan to adopt this guidance on January 1, 2023 and expect that it will have a material impact on the determination of our ALLL. We are unable to estimate the expected impact to the ALLL upon adoption due to various factors, primarily the fine tuning of our qualitative assumptions used within our preliminary model, uncertainty regarding economic conditions and the size and mix of our loan portfolio at the time of adoption, which could impact our historical loss factors. We are currently working with our existing ALLL software provider on further developing the model to perform the ALLL calculations upon adoption and we believe that we currently have in place the internal team capable of handling this implementation. In December 2019, the FASB issued ASU 2019-12, " Income Taxes (Topic 740), Simplifying the Accounting for Income Taxes," which eliminates certain exceptions to the guidance in ASC 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. This guidance is effective for public business entities for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. We adopted this guidance on January 1, 2021, and do not expect any material impact related to this pronouncement. In March 2020, the FASB issued ASU 2020-04, "Reference Rate Reform (Topic 848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting," which provides temporary optional expedients to ease the financial reporting burdens of the expected market transition from London Interbank Offered Rate (LIBOR) to an alternative reference rate such as Secured Overnight Financing Rate (SOFR). The guidance was effective upon issuance and generally can be applied through December 31, 2022. We are currently evaluating this guidance to determine the date of adoption and the impact on the Company. In October 2020, the FASB issued ASU 2020-08, "Codification Improvements to Subtopic 310-20, Receivables – Nonrefundable Fees and Other Costs," which clarified that for each reporting period, an entity should reevaluate whether a callable debt security is within the scope of paragraph 310-20-35-33 of the FASB Accounting Standards Codification. This guidance is effective for public business entities for fiscal years beginning after December 15, 2020 and interim periods within those fiscal years. We adopted this guidance on January 1, 2021.
Fair Value Measurements	Fair Value Measurements Under FASB Accounting Standards Codification (“ASC”) 820-10, we group assets and liabilities at fair value in three levels, based on the markets in which the assets and liabilities are traded and the reliability of the assumptions used to determine fair value. These levels are: Level 1 Valuation is based upon quoted prices for identical instruments traded in active markets. Level 2 Valuation is based upon quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable in the market. Level 3 Valuation is generated from model-based techniques that use at least one significant assumption not observable in the market. These unobservable assumptions reflect estimates of assumptions that market participants would use in pricing the asset or liability. Valuation techniques include use of option pricing models, discounted cash flow models and similar techniques. Risks with Fair Value Measurements Fair value estimates are made at a discrete point in time based on relevant market information and other information about the financial instruments. Because no active market exists for a significant portion of our financial instruments, fair value estimates are based in large part on judgments we make primarily regarding current economic conditions, risk characteristics of various financial instruments, prepayment rates, and future expected loss experience. These estimates are subjective in nature and invariably involve some inherent uncertainties. Additionally, the occurrence of unexpected events or changes in circumstances can occur that could require us to make changes to our assumptions and which, in turn, could significantly affect and require us to make changes to our previous estimates of fair value. In addition, the fair value estimates are based on existing on and off-balance sheet financial instruments without attempting to estimate the value of existing and anticipated future customer relationships and the value of assets and liabilities that are not considered financial instruments, such as premises and equipment and other real estate owned (“OREO”). Measurement Methodology Cash and Cash Equivalents. The fair value of cash and cash equivalents approximates its carrying value. Interest-Bearing Deposits with Financial Institutions. The fair values of interest-bearing deposits maturing within one year approximate their carrying values. FHLB and FRBSF Stock. The Bank is a member of the Federal Home Loan Bank of San Francisco (“FHLB”) and the FRBSF. As members, we are required to own stock of the FHLB and the FRBSF, the amount of which is based primarily on the level of our borrowings from those institutions. We also have the right to acquire additional shares of stock in either or both of the FHLB and the FRBSF. During the three months ended March 31, 2021, we purchased no FHLB or FRBSF stock. No shares of FHLB stock or FRBSF stock were called during the three months ended March 31, 2021. The fair values of the FHLB and FRBSF stock are equal to their respective carrying amounts, are classified as restricted securities and are periodically evaluated for impairment based on our assessment of the ultimate recoverability of our investments in that stock. Any cash or stock dividends paid to us on such stock are reported as income. Investment Securities Available for Sale. Fair value measurement for our investment securities available for sale is based upon quoted prices, if available. If quoted prices are not available, fair values are measured using independent pricing models or other model-based valuation techniques such as the present value of future cash flows, adjusted for the security’s credit rating, prepayment assumptions and other factors such as credit loss assumptions. Level 1 investment securities include those traded on an active exchange, such as the New York Stock Exchange, and U.S. Treasury securities that are traded by dealers or brokers in active over-the-counter markets. Level 2 investment securities include mortgage-backed securities issued by government sponsored entities, municipal bonds and corporate debt securities. Securities classified as Level 3 include asset-backed securities in less liquid markets. Equity Investments Without Readily Determinable Fair Value . Equity investments without readily determinable fair value are accounted for under the measurement alternative method of accounting. These investments are measured at cost, less any impairment, plus or minus any changes resulting from observable price changes in orderly transactions for an identical or similar investment of the same issuer. Any cash or stock dividends paid to us on such investments are reported as noninterest income. Impaired Loans . Loans measured for impairment are measured at an observable market price (if available), or the fair value of the loan’s collateral (if the loan is collateral dependent). The fair value of an impaired loan may be estimated using one of several methods, including collateral value, market value of similar debt, liquidation value and discounted cash flows. Those impaired loans not requiring a specific loan loss reserve represent loans for which the fair value of the expected repayments or collateral exceeds the recorded investments in such loans. When the fair value of the collateral is based on an observable market price or a current appraised value, we record the impaired loan at Level 2. When an appraised value is not available or we determine that the fair value of the collateral is further impaired below the appraised value and there is no observable market price, we record the impaired loan at Level 3. Loans . The fair value for loans with variable interest rates less a credit discount is the carrying amount. The fair value of fixed rate loans is derived by calculating the present value of expected future cash flows discounted at the loan’s original interest rate by the various homogeneous categories of loans. All loans have been adjusted to reflect changes in credit risk and represent the exit price of the loans. Changes are not recorded directly as an adjustment to current earnings or comprehensive income, but rather as an adjustment component in determining the overall adequacy of the loan loss reserve. Other Real Estate Owned. OREO is reported at its net realizable value (fair value less estimated costs to sell) at the time any real estate collateral is acquired by the Bank in satisfaction of a loan. Subsequently, OREO is carried at the lower of carrying value or fair value less estimated costs to sell. Fair value is determined based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral. When the fair value of the collateral is based on an observable market price or a current appraised value, we record the foreclosed asset at Level 2. When an appraised value is not available or management determines the fair value of the collateral is further impaired below the appraised value and there is no observable market price, we record the foreclosed asset at Level 3. Other Foreclosed Assets. Other foreclosed assets are reported at their net realizable value (fair value less estimated costs to sell) at the time any collateral other than real estate is acquired by the Bank in satisfaction of a loan. Subsequently, other foreclosed assets are carried at the lower of carrying value or fair value less estimated costs to sell. Fair value is determined based upon independent market prices, appraised values of the collateral or management’s estimation of the value of the collateral. When the fair value of the collateral is based on an observable market price or a current appraised value, we record the foreclosed asset at Level 2. When an appraised value is not available or management determines the fair value of the collateral is further impaired below the appraised value and there is no observable market price, we record the foreclosed asset at Level 3. Deposits. Deposits are carried at historical cost. The carrying amounts of deposits from savings and money market accounts are deemed to approximate fair value as they either have no stated maturities or short-term maturities. Certificates of deposit are estimated utilizing discounted cash flow techniques. The interest rates applied are rates currently being offered for similar certificates of deposit. Borrowings. The fair value of borrowings is the carrying amount for those borrowings that mature on a daily basis. The fair value of term borrowings is derived by calculating the discounted value of future cash flows expected to be paid out by the Company. We classify our borrowings in Level 2 of the fair value hierarchy. Junior Subordinated Debentures. The fair value of the junior subordinated debentures is based on quoted market prices of the underlying securities. These securities are variable rate in nature and repriced quarterly. We classify our junior subordinated debentures in Level 2 of the fair value hierarchy. Commitments to Extend Credit and Standby Letters of Credit. The fair value of commitments to extend credit and standby letters of credit are based on fees currently charged to enter into similar agreements, taking into account the remaining terms of the agreements and the counterparties’ credit standing.

Fair Value Measurements - (Tabl

Fair Value Measurements - (Tables)	3 Months Ended
	Mar. 31, 2021
Fair Value Disclosures [Abstract]
Schedule of assets and liabilities measured at fair value on recurring basis	The following tables show the recorded amounts of assets and liabilities measured at fair value on a recurring basis at March 31, 2021 and December 31, 2020: At March 31, 2021 (Dollars in thousands) Total Level 1 Level 2 Level 3 Assets at Fair Value: Debt securities available for sale Commercial mortgage backed securities issued by U.S. agencies $ 27,390 $ — $ 27,390 $ — Residential mortgage backed securities issued by U.S. agencies 7,854 — 7,854 — Corporate subordinated debt 7,984 — 7,984 — Total debt securities available for sale at fair value $ 43,228 $ — $ 43,228 $ — At December 31, 2020 (Dollars in thousands) Total Level 1 Level 2 Level 3 Assets at Fair Value: Debt securities available for sale Commercial mortgage backed securities issued by U.S. agencies $ 20,673 $ — $ 20,673 $ — Residential mortgage backed securities issued by U.S. agencies 14,436 — 14,436 — Corporate subordinated debt 7,074 — 7,074 — Total debt securities available for sale at fair value $ 42,183 $ — $ 42,183 $ —
Schedule of assets measured at fair value on nonrecurring basis	Information regarding assets measured at fair value on a nonrecurring basis is set forth in the table below. At March 31, 2021 At December 31, 2020 (Dollars in thousands) Total Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Assets at Fair Value: Impaired loans $ 26,148 $ — $ — $ 26,148 $ 39,916 $ — $ — $ 39,916 Other foreclosed assets 152 — 152 — 231 — 231 — Total $ 26,300 $ — $ 152 $ 26,148 $ 40,147 $ — $ 231 $ 39,916
Summary of significant unobservable inputs and valuation techniques	For our fair value measurements classified in Level 3 of the fair value hierarchy as of March 31, 2021, a summary of the significant unobservable inputs and valuation techniques is as follows: Fair Value Measurement as of March 31, 2021 Valuation Techniques (2) Unobservable Inputs (2) Range Weighted Average (Dollars in thousands) Assets Impaired loans $ 26,148 Third-Party Pricing Discounted cash flow N/A (1) N/A (1) (1) As part of our process, we obtain appraisals for our various properties included within impaired loans which primarily rely upon market comparisons. These market comparisons support our assumption that the carrying value of the respective loans either requires or does not require additional impairment.
Schedule of estimated fair values and amounts of financial instruments	The table below provides estimated fair values and related carrying amounts of our financial instruments as of March 31, 2021 and December 31, 2020, excluding financial assets and liabilities which are recorded at fair value on a recurring basis. Estimated Fair Value At March 31, 2021 At December 31, 2020 Carrying Value Total Level 1 Level 2 Level 3 Carrying Value Total Level 1 Level 2 Level 3 (Dollars in thousands) Financial assets: Cash and cash equivalents $ 258,386 $ 258,386 $ 258,386 $ — $ — $ 286,269 $ 286,269 286,269 — — Interest-bearing deposits with financial institutions 1,597 1,597 1,597 — — 1,597 1,597 1,597 — — Federal Reserve Bank of San Francisco and Federal Home Loan Bank stock 7,910 7,910 7,910 — — 7,910 7,910 7,910 — — Loans, net 1,227,645 1,238,435 — — 1,238,435 1,209,587 1,218,096 — — 1,218,096 Accrued interest receivable 6,667 6,667 6,667 — — 5,666 5,666 5,666 — — Financial liabilities: Noninterest bearing deposits 649,407 649,407 649,407 — — 647,115 647,115 647,115 — — Interest-bearing deposits 734,364 735,228 — 735,228 — 736,232 737,888 — 737,888 — FHLB borrowings — — — — — 10,000 10,009 — 10,009 — Junior subordinated debentures 17,527 17,527 — 17,527 — 17,527 17,527 — 17,527 — Accrued interest payable 144 144 144 — — 188 188 188 — —

Investments - (Tables)

Investments - (Tables)	3 Months Ended
	Mar. 31, 2021
Investments [Abstract]
Schedule of major components of securities available for sale and comparison of amortized cost, estimated fair market values, and gross unrealized gains and losses	The following table sets forth the major components of securities available for sale and compares the amortized costs and estimated fair market values of, and the gross unrealized gains and losses on, these securities at March 31, 2021 and December 31, 2020: (Dollars in thousands) March 31, 2021 December 31, 2020 Amortized Gross Unrealized Estimated Amortized Gross Unrealized Estimated Gain Loss Gain Loss Securities Available for Sale Commercial mortgage backed securities issued by U.S. Agencies (1) $ 28,578 $ 95 $ (1,283) $ 27,390 $ 20,585 $ 214 $ (126) $ 20,673 Residential mortgage backed securities issued by U.S. Agencies (2) 7,763 94 (3) 7,854 14,061 379 (4) 14,436 Corporate subordinated debt 8,033 27 (76) 7,984 7,035 42 (3) 7,074 Total $ 44,374 $ 216 $ (1,362) $ 43,228 $ 41,681 $ 635 $ (133) $ 42,183 (1) Secured by first liens on commercial apartment building mortgages. (2) Secured by closed-end first liens on 1-4 family residential mortgages.
Schedule of amortized cost and estimated fair values of securities available for sale by contractual maturities and historical prepayments based on prior twelve months of principal payments	The amortized cost and estimated fair values of securities available for sale at March 31, 2021 and December 31, 2020 are shown in the tables below by contractual maturities taking into consideration historical prepayments based on the prior twelve months of principal payments. Expected maturities will differ from contractual maturities and historical prepayments, particularly with respect to collateralized mortgage obligations, primarily because prepayment rates are affected by changes in conditions in the interest rate market and, therefore, future prepayment rates may differ from historical prepayment rates. At March 31, 2021 Maturing in (Dollars in thousands) One year Over one Over five Over ten Total Securities available for sale, amortized cost $ 3,539 $ 17,430 $ 11,210 $ 12,195 $ 44,374 Securities available for sale, estimated fair value 3,558 17,490 10,900 11,280 43,228 Weighted average yield 1.24 % 2.45 % 1.14 % 1.40 % 1.73 % At December 31, 2020 Maturing in (Dollars in thousands) One year Over one Over five Over ten Total Securities available for sale, amortized cost $ 5,657 $ 19,953 $ 6,368 $ 9,703 $ 41,681 Securities available for sale, estimated fair value 5,770 20,353 6,422 9,638 42,183 Weighted average yield 1.27 % 2.27 % 1.27 % 1.38 % 1.77 %
Schedule of gross unrealized losses and fair values of investments	The tables below indicate, as of March 31, 2021 and December 31, 2020, the gross unrealized losses and fair values of our investments, aggregated by investment category, and length of time that the individual securities have been in a continuous unrealized loss position. Securities with Unrealized Loss at March 31, 2021 Less than 12 months 12 months or more Total (Dollars in thousands) Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized Commercial mortgage backed securities issued by U.S. Agencies $ 7,105 $ (1,283) $ — $ — $ 7,105 $ (1,283) Residential mortgage backed securities issued by U.S. Agencies 65 (1) 124 (2) 189 (3) Corporate subordinated debt 3,957 (76) — — 3,957 (76) Total $ 11,127 $ (1,360) $ 124 $ (2) $ 11,251 $ (1,362) Securities with Unrealized Loss at December 31, 2020 Less than 12 months 12 months or more Total (Dollars in thousands) Fair Value Unrealized Fair Value Unrealized Fair Value Unrealized Commercial mortgage backed securities issued by U.S. Agencies $ 7,483 $ (126) $ — $ — $ 7,483 $ (126) Residential mortgage backed securities issued by U.S. Agencies 68 (1) 126 (3) 194 (4) Corporate subordinated debt 4,032 (3) — — 4,032 (3) Total $ 11,583 $ (130) $ 126 $ (3) $ 11,709 $ (133)
Schedule of other investments	As of March 31, 2021 and December 31, 2020, our equity investments without readily determinable fair value were as follows: March 31, 2021 December 31, 2020 (Dollars in thousands) Equity investments without readily determinable fair value $ 2,731 $ 2,673

Loans and Allowance for Loan _2

Loans and Allowance for Loan and Lease Losses - (Tables)	3 Months Ended
	Mar. 31, 2021
Receivables [Abstract]
Schedule of composition of loan portfolio	The loan portfolio consisted of the following at: March 31, 2021 December 31, 2020 Amount Percent Amount Percent (Dollars in thousands) Commercial loans, excluding PPP $ 321,319 25.8 % $ 337,427 27.6 % Commercial loans - PPP 280,562 22.5 % 229,728 18.8 % Commercial real estate loans – owner occupied 189,203 15.2 % 197,336 16.1 % Commercial real estate loans – all other 197,026 15.8 % 194,893 15.9 % Residential mortgage loans – multi-family 157,646 12.7 % 159,182 13.0 % Residential mortgage loans – single family 10,085 0.8 % 12,766 1.0 % Construction and land development loans 11,840 1.0 % 11,766 1.0 % Consumer loans 76,669 6.2 % 80,759 6.6 % Gross loans 1,244,350 100.0 % 1,223,857 100.0 % Deferred costs, net 422 3,182 Allowance for loan and lease losses (17,127) (17,452) Loans, net $ 1,227,645 $ 1,209,587
Schedule of allowance for loan losses and loan balances	Set forth below is a summary of the activity in the ALLL, by portfolio type, during the three months ended March 31, 2021 and 2020: Commercial Commercial Real Estate Construction and Land Consumer Unallocated Total (Dollars in thousands) ALLL in the three months ended March 31, 2021: Balance at beginning of period $ 11,255 $ — $ 3,964 $ 137 $ 2,096 $ — $ 17,452 Charge offs (525) — — — (13) — (538) Recoveries 209 — — — 4 — 213 Provision (316) — 489 29 (202) — — Balance at end of period $ 10,623 $ — $ 4,453 $ 166 $ 1,885 $ — $ 17,127 ALLL in the three months ended March 31, 2020: Balance at beginning of period $ 8,883 $ — $ 2,897 $ 34 $ 1,797 $ — $ 13,611 Charge offs (2,250) — — — (64) — (2,314) Recoveries 19 — — — 4 — 23 Provision 4,566 — 1,471 21 142 — 6,200 Balance at end of period $ 11,218 $ — $ 4,368 $ 55 $ 1,879 $ — $ 17,520 Set forth below is information regarding loan balances and the related ALLL, by portfolio type, as of March 31, 2021 and December 31, 2020. Commercial Commercial Real Estate Construction and Land Consumer Unallocated Total (Dollars in thousands) ALLL balance at March 31, 2021 related to: Loans individually evaluated for impairment $ 1,962 $ — $ — $ — $ — $ — $ 1,962 Loans collectively evaluated for impairment 8,661 — 4,453 166 1,885 — 15,165 Total $ 10,623 $ — $ 4,453 $ 166 $ 1,885 $ — $ 17,127 Loan balance at March 31, 2021 related to: Loans individually evaluated for impairment $ 20,452 $ — $ 5,389 $ — $ — $ — $ 25,841 Loans collectively evaluated for impairment 300,867 280,562 538,486 11,840 86,754 — 1,218,509 Total $ 321,319 $ 280,562 $ 543,875 $ 11,840 $ 86,754 $ — $ 1,244,350 ALLL balance at December 31, 2020 related to: Loans individually evaluated for impairment $ 2,711 $ — $ — $ — $ — $ — $ 2,711 Loans collectively evaluated for impairment 8,544 — 3,964 137 2,096 — 14,741 Total $ 11,255 $ — $ 3,964 $ 137 $ 2,096 $ — $ 17,452 Loan balance at December 31, 2020 related to: Loans individually evaluated for impairment $ 30,886 $ — $ 6,661 $ — $ — $ — $ 37,547 Loans collectively evaluated for impairment 306,541 229,728 544,751 11,766 93,525 — 1,186,310 Total $ 337,427 $ 229,728 $ 551,412 $ 11,766 $ 93,525 $ — $ 1,223,857
Summary of delinquency status of loans by portfolio type	The following table provides a summary of the delinquency status of loans by portfolio type at March 31, 2021 and December 31, 2020: 30-59 Days Past Due 60-89 Days Past Due 90 Days and Greater Total Past Due Current Total Loans Outstanding Loans >90 Days and Accruing (Dollars in thousands) At March 31, 2021 Commercial loans, excluding PPP $ 1,367 $ 80 $ 578 $ 2,025 $ 319,294 $ 321,319 $ — Commercial loans - PPP — — — — 280,562 280,562 — Commercial real estate loans – owner-occupied — — — — 189,203 189,203 — Commercial real estate loans – — — — — 197,026 197,026 — Residential mortgage loans – — — — — 157,646 157,646 — Residential mortgage loans – — — — — 10,085 10,085 — Construction and land development loans — — — — 11,840 11,840 — Consumer loans 89 13 45 147 76,522 76,669 — Total $ 1,456 $ 93 $ 623 $ 2,172 $ 1,242,178 $ 1,244,350 $ — At December 31, 2020 Commercial loans, excluding PPP $ 5,281 $ 3,646 $ 9,670 $ 18,597 $ 318,830 $ 337,427 $ 5,675 Commercial loans - PPP — — — — 229,728 229,728 — Commercial real estate loans – owner-occupied — — — — 197,336 197,336 — Commercial real estate loans – — — 1,837 1,837 193,056 194,893 — Residential mortgage loans – — — — — 159,182 159,182 — Residential mortgage loans – — — — — 12,766 12,766 — Construction and land development loans — — — — 11,766 11,766 — Consumer loans — 65 — 65 80,694 80,759 — Total $ 5,281 $ 3,711 $ 11,507 $ 20,499 $ 1,203,358 $ 1,223,857 $ 5,675
Schedule of loans on nonaccrual status by portfolio type	The following table provides information with respect to loans on nonaccrual status, by portfolio type, as of March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 (Dollars in thousands) Nonaccrual loans: Commercial loans $ 19,426 $ 30,928 Commercial real estate loans – owner occupied 952 6,978 Commercial real estate loans – all other — 1,836 Consumer 181 174 Total (1) $ 20,559 $ 39,916
Summary of loans by portfolio type and internal credit quality ratings	The following table provides a summary of loans by portfolio type and our internal asset quality ratings as of March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 (Dollars in thousands) Pass: Commercial loans, excluding PPP $ 271,240 $ 263,616 Commercial loans - PPP 280,562 229,728 Commercial real estate loans – owner occupied 167,057 162,250 Commercial real estate loans – all other 196,243 192,264 Residential mortgage loans – multi family 156,678 158,816 Residential mortgage loans – single family 10,085 12,766 Construction and land development loans 11,340 11,766 Consumer loans 76,481 80,576 Total pass loans $ 1,169,686 $ 1,111,782 Special Mention: Commercial loans $ 10,667 $ 13,763 Commercial real estate loans – owner occupied — 6,882 Commercial real estate loans – all other — 793 Residential mortgage loans – multi family 969 366 Total special mention loans $ 11,636 $ 21,804 Substandard: Commercial loans $ 39,305 $ 59,408 Commercial real estate loans – owner occupied 22,145 28,203 Commercial real estate loans – all other 783 1,837 Construction and land development loans 500 — Consumer loans 188 182 Total substandard loans $ 62,921 $ 89,630 Doubtful: Commercial loans $ 107 $ 641 Total doubtful loans $ 107 $ 641 Total Loans: $ 1,244,350 $ 1,223,857
Schedule of Impaired Loans	The following table sets forth information regarding impaired loans, at March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 (Dollars in thousands) Impaired loans: Nonaccruing loans $ 17,064 $ 33,204 Nonaccruing restructured loans 3,495 6,712 Accruing restructured loans (1) 5,589 — Total impaired loans $ 26,148 $ 39,916 Impaired loans less than 90 days delinquent and included in total impaired loans $ 25,525 $ 34,085 (1) See “ Troubled Debt Restructurings ” below for a description of accruing restructured loans at March 31, 2021 and December 31, 2020. The table below contains additional information with respect to impaired loans, by portfolio type, as of March 31, 2021 and December 31, 2020: March 31, 2021 December 31, 2020 Recorded Investment Unpaid Principal Balance Related Allowance (1) Recorded Investment Unpaid Principal Balance Related Allowance (1) (Dollars in thousands) No allowance recorded: Commercial loans, excluding PPP $ 5,627 $ 11,935 $ — $ 10,970 $ 19,530 $ — Commercial real estate loans – owner occupied 5,479 6,198 — 6,978 7,633 — Commercial real estate loans – all other — — — 1,836 1,837 — Consumer loans 181 222 — 174 197 — Total $ 11,287 $ 18,355 $ — $ 19,958 $ 29,197 $ — With allowance recorded: Commercial loans, excluding PPP $ 14,861 $ 15,041 $ 1,962 $ 19,958 $ 20,040 $ 2,711 Total $ 14,861 $ 15,041 $ 1,962 $ 19,958 $ 20,040 $ 2,711 All impaired loans Commercial loans, excluding PPP $ 20,488 $ 26,976 $ 1,962 $ 30,928 $ 39,570 $ 2,711 Commercial real estate loans – owner occupied 5,479 6,198 — 6,978 7,633 — Commercial real estate loans – all other — — — 1,836 1,837 — Consumer loans 181 222 — 174 197 — Total $ 26,148 $ 33,396 $ 1,962 $ 39,916 $ 49,237 $ 2,711 (1) When the discounted cash flows, collateral value or market price equals or exceeds the recorded investment in the loan, then specific reserves are not required to be set aside for the loan within the ALLL. This typically occurs when the impaired loans have been partially charged-off and/or there have been interest payments received and applied to the balance of the principal outstanding. Average balances and interest income recognized on impaired loans, by portfolio type, for the three months ended March 31, 2021 and 2020 were as follows: Three Months Ended March 31, 2021 2020 Average Balance Interest Income Recognized Average Balance Interest Income Recognized (Dollars in thousands) No allowance recorded: Commercial loans, excluding PPP $ 8,298 $ 54 $ 10,178 $ — Commercial real estate loans – owner occupied 6,228 — 6,438 — Commercial real estate loans – all other 918 — — — Consumer loans 178 — 130 — Total 15,622 54 16,746 — With allowance recorded: Commercial loans, excluding PPP 17,410 1,105 — Total 17,410 — 1,105 — Total Commercial loans, excluding PPP 25,708 54 11,283 — Commercial real estate loans – owner occupied 6,228 — 6,438 — Commercial real estate loans – all other 918 — — — Consumer loans 178 — 130 — Total $ 33,032 $ 54 $ 17,851 $ —
Schedule of loans restructured as TDRs	The following table presents loans restructured as TDRs during the three months ended March 31, 2021 and 2020: Three Months Ended March 31, 2021 March 31, 2020 (Dollars in thousands) Number of Pre-Modification Post-Modification Number of Pre-Modification Post-Modification Performing Commercial loans 2 $ 2,639 $ 1,062 — $ — $ — Commercial real estate – owner occupied 1 4,929 4,527 — — — 3 7,568 5,589 — — — Nonperforming Commercial loans 5 $ 5,266 $ 3,495 — $ — $ — 5 5,266 3,495 — — — Total Troubled Debt Restructurings (1) 8 $ 12,834 $ 9,084 — $ — $ — (1) No outstanding loans were restructured during the three months ended March 31, 2020.

Leases - (Tables)

Leases - (Tables)	3 Months Ended
	Mar. 31, 2021
Leases [Abstract]
Summary of lease cost and payments	During the three months ended March 31, 2021 and 2020, we recognized rent expense associated with our leases as follows: Three Months Ended March 31, 2021 2020 Lease cost (Dollars in thousands) Finance lease cost: Operating lease cost $ 605 $ 609 Short-term lease cost (1) 37 35 Total lease cost $ 642 $ 644 Weighted-average remaining lease term—operating leases (in years) 4.12 5.12 (1) Includes leases that are less than 12 months and equipment leases that are accounted for on a cash basis. and 2020 , we had the following cash and noncash activities associated with our leases: Three Months Ended March 31, Three Months Ended March 31, 2021 2020 (Dollars in thousands) Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases (fixed payments) $ 610 $ 572 Noncash activities: Right-of-use assets obtained in exchange for new operating lease liabilities $ — $ —
Summary of lease assets and liabilities	Supplemental balance sheet information related to leases was as follows: Financial Statement Classification March 31, 2021 December 31, 2020 (Dollars in thousands) Operating right-of-use assets Other assets $ 9,457 $ 10,002 Operating lease liabilities Other liabilities $ 10,383 $ 10,933
Summary of maturity of lease liabilities	Maturities of operating lease liabilities as of March 31, 2021 are as follows: (Dollars in thousands) For the years ending December 31, Remainder of 2021 $ 1,879 2022 2,575 2023 2,662 2024 2,750 2025 1,021 2025 and beyond — Total 10,887 Less: Imputed interest (504) Total Lease liabilities $ 10,383

Stock-Based Employee Compensa_2

Stock-Based Employee Compensation Plans - (Tables)	3 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of stock option activity under plans	The following table summarizes the stock option activity under the Company’s equity incentive plans during the three months ended March 31, 2021 and 2020, respectively. Number of Weighted- Number of Weighted- 2021 2020 Outstanding – January 1, 589,587 $ 7.01 1,009,466 $ 6.98 Granted — — — — Exercised (16,000) 4.34 (10,728) 4.66 Forfeited/Canceled — — (360,078) 6.92 Outstanding – March 31, 573,587 7.09 638,660 7.05 Options Exercisable – March 31, 361,545 $ 6.93 344,581 $ 6.74 Options Vested – March 31, 361,545 $ 6.93 344,581 $ 6.74
Schedule of additional information regarding vested and unvested options outstanding	The following table provides additional information regarding the vested and unvested options that were outstanding at March 31, 2021. Options Outstanding as of March 31, 2021 Options Exercisable as of March 31, 2021 (1) Exercise Price Vested Unvested Weighted Weighted Shares Weighted $2.97 – $3.99 12,000 — $ 3.74 0.82 12,000 $ 3.74 $4.00 – $5.99 — — — — — — $6.00 – $6.99 202,189 5,450 6.61 3.87 202,189 6.60 $7.00 – $7.99 84,157 200,000 7.30 7.88 84,157 7.24 $8.00 – $8.40 63,199 6,592 8.21 6.90 63,199 8.19 361,545 212,042 $ 7.09 6.16 361,545 $ 6.93 (1) The weighted average remaining contractual life of the options that were exercisable as of March 31, 2021 was 4.91 years.
Summary of status of unvested options and changes in number of shares subject to and in weighted average grant date fair values of unvested options	A summary of the status of the unvested options outstanding as of March 31, 2021 and 2020, and changes in the weighted average grant date fair values of the unvested options during the three months ended March 31, 2021 and 2020, are set forth in the following table. For the three months ended March 31, 2021 2020 Number of Weighted Number of Weighted Unvested at the beginning of the period 233,107 $ 2.10 334,322 $ 2.19 Granted — — — — Vested (21,065) 2.81 (29,409) 2.81 Forfeited/Canceled — — (10,834) 2.82 Unvested at the end of the period 212,042 2.03 294,079 2.11
Schedule of restricted stock and stock units activity	Restricted Stock The following table summarizes the activity related to restricted stock granted, vested and forfeited under our equity incentive plans during the three months ended March 31, 2021 and 2020. For the three months ended March 31, 2021 2020 Number of Shares Average Grant Date Fair Value Per Share Number of Shares Average Grant Date Fair Value Per Share Outstanding at the beginning of the period 123,165 $ 6.63 124,202 $ 8.44 Granted 112,970 6.68 37,739 6.99 Vested (41,888) 7.71 (39,889) 8.59 Forfeited — — (18,357) 8.25 Outstanding at the end of the period 194,247 $ 6.43 103,695 $ 7.90 Stock Units The following table summarizes the activity related to stock units granted, vested and forfeited under our equity incentive plans during the three months ended March 31, 2021 and 2020. For the three months ended March 31, 2021 2020 Number of Shares Average Grant Date Fair Value Per Share Number of Shares Average Grant Date Fair Value Per Share Outstanding at January 1, 75,000 $ 7.33 100,000 $ 7.33 Granted — — — — Vested — — — — Forfeited — — — — Outstanding at March 31, 75,000 $ 7.33 100,000 $ 7.33
Schedule of compensation expense of non-vested stock options outstanding	We expect that the compensation expense that will be recognized during the periods presented below in respect to stock options, restricted stock, and stock units outstanding at March 31, 2021, will be as follows: Estimated Stock Based Compensation Expense Stock Options Estimated Stock Based Compensation Expense Restricted Stock Estimated Stock Based Compensation Expense Stock Units Estimated Stock Based Compensation Expense Total (Dollars in thousands) For the years ending December 31, Remainder of 2021 $ 85 $ 448 $ 184 $ 717 2022 109 346 164 619 2023 101 260 — 361 2024 67 48 — 115 2024 and beyond — 10 — 10 $ 362 $ 1,112 $ 348 $ 1,822

Earnings Per Share ("EPS") - (T

Earnings Per Share ("EPS") - (Tables)	3 Months Ended
	Mar. 31, 2021
Earnings Per Share [Abstract]
Schedule of computation of basic and diluted earnings per share	The following table shows how we computed basic and diluted EPS for the three months ended March 31, 2021 and 2020. (In thousands, except per share data) For the Three Months Ended March 31, 2021 2020 Basic EPS: Net income (loss) $ 3,388 $ (2,361) Net income (loss) allocable to common shareholders $ 3,388 $ (2,361) Less earnings allocated to participating securities 33 — Earnings (loss) allocated to common shareholders $ 3,355 $ (2,361) Weighted average common shares outstanding 23,562 23,475 Basic earnings (loss) per common share $ 0.14 $ (0.10) Diluted EPS: Earnings (loss) allocated to common shareholders $ 3,388 $ (2,361) Weighted average common shares outstanding 23,562 23,475 Add dilutive effects of restricted stock grants 158 — Add dilutive effects of restricted stock units 75 — Add dilutive effects for stock options 18 — Weighted average diluted common shares outstanding 23,813 23,475 Diluted earnings (loss) per common share $ 0.14 $ (0.10) (1) The basic and diluted earnings per share amounts for the three months ended March 31, 2021 and 2020 are the same under both the Treasury Stock Method and the Two-Class Method as prescribed in FASB ASC 260-10, Earnings Per Share
Schedule of antidilutive securities excluded from earnings per share	The weighted average shares that have an antidilutive effect in the calculation of diluted net income per share and have been excluded from the computations above were as follows: For the Three Months Ended March 31, 2021 2020 Stock options (1)(2) 377,198 800,960 (1) Stock options that were excluded from the computation of diluted earnings per common share for the three months ended March 31, 2021 and 2020 as a result of the reported net loss available to common shareholders.

Shareholders' Equity - (Tables)

Shareholders' Equity - (Tables)	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Schedule of accumulated other comprehensive income (loss), net	Accumulated other comprehensive income (loss), net as of March 31, 2021 and December 31, 2020 was as follows: Unrealized Gain (Loss) on Securities Available-for-Sale, net of tax Accumulated Other Comprehensive Income (Loss), Net (Dollars in thousands) Beginning balance as of January 1, 2019 $ (1,144) $ (1,144) Other comprehensive loss, net of tax of $62 thousand 577 577 Ending balance as of December 31, 2019 $ (567) $ (567) Other comprehensive income, net of tax of $202 thousand 483 483 Ending balance as of December 31, 2020 $ (84) $ (84) Other comprehensive income, net of tax of $487 thousand (1,161) (1,161) Ending balance as of March 31, 2021 $ (1,245) $ (1,245)

Commitments and Contingencies -

Commitments and Contingencies - (Tables)	3 Months Ended
	Mar. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
Schedule of borrowings and contractual obligations	At March 31, 2021 and December 31, 2020, our borrowings and contractual obligations consisted of the following: (Dollars in thousands) March 31, 2021 December 31, 2020 FHLB advances—short-term $ — $ 10,000 Total $ — $ 10,000

Business Segment Information -

Business Segment Information - (Tables)	3 Months Ended
	Mar. 31, 2021
Segment Reporting [Abstract]
Schedule of net interest income and noninterest income	The following table sets forth information regarding the net interest income and noninterest income for our commercial banking segment for the three months ended March 31, 2021 and 2020. (Dollars in thousands) Commercial Other (1) Total Net interest income for the three months ended March 31, 2021 $ 12,861 $ (122) $ 12,739 2020 $ 11,670 $ (197) $ 11,473 Noninterest income for the three months ended March 31, 2021 $ 1,734 $ 4 $ 1,738 2020 $ 1,089 $ 6 $ 1,095 Segment Assets at: March 31, 2021 $ 1,579,123 $ 914 $ 1,580,037 December 31, 2020 $ 1,586,916 $ 674 $ 1,587,590 (1) Represents net interest income (loss) and noninterest income for PMBC.

Regulatory Capital - (Tables)

Regulatory Capital - (Tables)	3 Months Ended
	Mar. 31, 2021
Broker-Dealer, Net Capital Requirement, SEC Regulation [Abstract]
Schedule of actual amount and capital ratios of company and bank	The following table sets forth the capital and capital ratios of the Bank (on a stand-alone basis) at March 31, 2021, as compared to the regulatory requirements applicable to it. Applicable Federal Regulatory Requirement For Capital To be Categorized As Amount Ratio Amount Ratio Amount Ratio (Dollars in thousands) Total Capital to Risk Weighted Assets $ 187,050 16.8 % $ 133,331 At least 8.625 $ 111,678 At least 10.0 Common Equity Tier 1 Capital to Risk Weighted Assets $ 173,047 15.5 % $ 57,235 At least 5.125 $ 72,591 At least 6.5 Tier 1 Capital to Risk Weighted Assets $ 173,047 15.5 % $ 73,987 At least 6.625 $ 89,343 At least 8.0 Tier 1 Capital to Average Assets $ 173,047 11.2 % $ 61,835 At least 4.0 $ 77,294 At least 5.0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details)	3 Months Ended
	Mar. 31, 2021USD ($)shares
Fair Value Disclosures [Abstract]
Payments to acquire FHLB stock | $	$ 0
Number of FHLB stock sold (in shares) | shares	0

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of assets and liabilities measured at fair value on recurring basis (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	$ 43,228	$ 42,183
Commercial mortgage backed securities issued by U.S. agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	27,390	20,673
Residential mortgage backed securities issued by U.S. agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	7,854	14,436
Corporate subordinated debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	7,984	7,074
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	43,228	42,183
Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	0	0
Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	43,228	42,183
Recurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	0	0
Recurring | Commercial mortgage backed securities issued by U.S. agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	27,390	20,673
Recurring | Commercial mortgage backed securities issued by U.S. agencies | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	0	0
Recurring | Commercial mortgage backed securities issued by U.S. agencies | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	27,390	20,673
Recurring | Commercial mortgage backed securities issued by U.S. agencies | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	0	0
Recurring | Residential mortgage backed securities issued by U.S. agencies
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	7,854	14,436
Recurring | Residential mortgage backed securities issued by U.S. agencies | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	0	0
Recurring | Residential mortgage backed securities issued by U.S. agencies | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	7,854	14,436
Recurring | Residential mortgage backed securities issued by U.S. agencies | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	0	0
Recurring | Corporate subordinated debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	7,984	7,074
Recurring | Corporate subordinated debt | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	0	0
Recurring | Corporate subordinated debt | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	7,984	7,074
Recurring | Corporate subordinated debt | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Securities available for sale, at fair value	$ 0	$ 0

Fair Value Measurements - Sch_2

Fair Value Measurements - Schedule of assets measured at fair value on nonrecurring basis (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Level 3 | Impaired loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	$ 26,148
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	26,300	$ 40,147
Nonrecurring | Impaired loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	26,148	39,916
Nonrecurring | Other foreclosed assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	152	231
Nonrecurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	0	0
Nonrecurring | Level 1 | Impaired loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	0	0
Nonrecurring | Level 1 | Other foreclosed assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	0	0
Nonrecurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	152	231
Nonrecurring | Level 2 | Impaired loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	0	0
Nonrecurring | Level 2 | Other foreclosed assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	152	231
Nonrecurring | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	26,148	39,916
Nonrecurring | Level 3 | Impaired loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	26,148	39,916
Nonrecurring | Level 3 | Other foreclosed assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
Fair value of assets on nonrecurring basis	$ 0	$ 0

Fair Value Measurements - Summa

Fair Value Measurements - Summary of significant unobservable inputs and valuation techniques (Details) $ in Thousands	Mar. 31, 2021USD ($)
Impaired loans | Level 3
Fair Value Inputs, Assets, Quantitative Information
Assets, fair value disclosure	$ 26,148

Fair Value Measurements - Sch_3

Fair Value Measurements - Schedule of estimated fair values and amounts of financial instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Level 1
Financial assets:
Cash and cash equivalents	$ 258,386	$ 286,269
Interest-bearing deposits with financial institutions	1,597	1,597
Federal Reserve Bank of San Francisco and Federal Home Loan Bank stock	7,910	7,910
Loans, net	0	0
Accrued interest receivable	6,667	5,666
Financial liabilities:
Noninterest bearing deposits	649,407	647,115
Interest-bearing deposits	0	0
FHLB borrowings	0	0
Junior subordinated debentures	0	0
Accrued interest payable	144	188
Level 2
Financial assets:
Cash and cash equivalents	0	0
Interest-bearing deposits with financial institutions	0	0
Federal Reserve Bank of San Francisco and Federal Home Loan Bank stock	0	0
Loans, net	0	0
Accrued interest receivable	0	0
Financial liabilities:
Noninterest bearing deposits	0	0
Interest-bearing deposits	735,228	737,888
FHLB borrowings	0	10,009
Junior subordinated debentures	17,527	17,527
Accrued interest payable	0	0
Level 3
Financial assets:
Cash and cash equivalents	0	0
Interest-bearing deposits with financial institutions	0	0
Federal Reserve Bank of San Francisco and Federal Home Loan Bank stock	0	0
Loans, net	1,238,435	1,218,096
Accrued interest receivable	0	0
Financial liabilities:
Noninterest bearing deposits	0	0
Interest-bearing deposits	0	0
FHLB borrowings	0	0
Junior subordinated debentures	0	0
Accrued interest payable	0	0
Carrying Value
Financial assets:
Cash and cash equivalents	258,386	286,269
Interest-bearing deposits with financial institutions	1,597	1,597
Federal Reserve Bank of San Francisco and Federal Home Loan Bank stock	7,910	7,910
Loans, net	1,227,645	1,209,587
Accrued interest receivable	6,667	5,666
Financial liabilities:
Noninterest bearing deposits	649,407	647,115
Interest-bearing deposits	734,364	736,232
FHLB borrowings	0	10,000
Junior subordinated debentures	17,527	17,527
Accrued interest payable	144	188
Total
Financial assets:
Cash and cash equivalents	258,386	286,269
Interest-bearing deposits with financial institutions	1,597	1,597
Federal Reserve Bank of San Francisco and Federal Home Loan Bank stock	7,910	7,910
Loans, net	1,238,435	1,218,096
Accrued interest receivable	6,667	5,666
Financial liabilities:
Noninterest bearing deposits	649,407	647,115
Interest-bearing deposits	735,228	737,888
FHLB borrowings	0	10,009
Junior subordinated debentures	17,527	17,527
Accrued interest payable	$ 144	$ 188

Investments - Schedule of major

Investments - Schedule of major components of securities available for sale (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale
Amortized Cost	$ 44,374	$ 41,681
Gross unrealized gain	216	635
Gross unrealized loss	(1,362)	(133)
Estimated Fair Value	43,228	42,183
Commercial mortgage backed securities issued by U.S. agencies
Debt Securities, Available-for-sale
Amortized Cost	28,578	20,585
Gross unrealized gain	95	214
Gross unrealized loss	(1,283)	(126)
Estimated Fair Value	27,390	20,673
Residential mortgage backed securities issued by U.S. agencies
Debt Securities, Available-for-sale
Amortized Cost	7,763	14,061
Gross unrealized gain	94	379
Gross unrealized loss	(3)	(4)
Estimated Fair Value	7,854	14,436
Corporate subordinated debt
Debt Securities, Available-for-sale
Amortized Cost	8,033	7,035
Gross unrealized gain	27	42
Gross unrealized loss	(76)	(3)
Estimated Fair Value	$ 7,984	$ 7,074

Investments - Narrative (Detail

Investments - Narrative (Details)	3 Months Ended
	Mar. 31, 2021USD ($)investment	Mar. 31, 2020USD ($)	Dec. 31, 2020USD ($)
Investments [Abstract]
Aggregate fair market value of securities pledged as collateral	$ 1,600,000		$ 2,000,000
Payments acquire debt securities	10,000,000	$ 0
Proceeds from sale of debt securities available for sale	5,700,000	0
Net gain on sale	140,000
Other-than-temporary impairment loss, available for sale securities	$ 0	0
Number of investments in limited partnerships | investment	3
Capital contributions, investments	$ 58,000	$ 0

Investments - Schedule of amort

Investments - Schedule of amortized cost and estimated fair value by contractual maturities (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Securities available for sale, amortized cost
One year or less	$ 3,539	$ 5,657
Over one year through five years	17,430	19,953
Over five years through ten years	11,210	6,368
Over ten Years	12,195	9,703
Amortized Cost	44,374	41,681
Securities available for sale, estimated fair value
One year or less	3,558	5,770
Over one year through five years	17,490	20,353
Over five years through ten years	10,900	6,422
Over ten Years	11,280	9,638
Total	$ 43,228	$ 42,183
Weighted average yield
One year or less	1.24%	1.27%
Over one year through five years	2.45%	2.27%
Over five years through ten years	1.14%	1.27%
Over ten Years	1.40%	1.38%
Total	1.73%	1.77%

Investments - Schedule of secur

Investments - Schedule of securities in continuous unrealized loss position (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Debt Securities, Available-for-sale
Less than 12 months, fair value	$ 11,127	$ 11,583
Less than 12 months, unrealized loss	(1,360)	(130)
12 months or more, fair value	124	126
12 months or more, unrealized loss	(2)	(3)
Total, fair value	11,251	11,709
Total, unrealized loss	(1,362)	(133)
Commercial mortgage backed securities issued by U.S. agencies
Debt Securities, Available-for-sale
Less than 12 months, fair value	7,105	7,483
Less than 12 months, unrealized loss	(1,283)	(126)
12 months or more, fair value	0	0
12 months or more, unrealized loss	0	0
Total, fair value	7,105	7,483
Total, unrealized loss	(1,283)	(126)
Residential mortgage backed securities issued by U.S. Agencies
Debt Securities, Available-for-sale
Less than 12 months, fair value	65	68
Less than 12 months, unrealized loss	(1)	(1)
12 months or more, fair value	124	126
12 months or more, unrealized loss	(2)	(3)
Total, fair value	189	194
Total, unrealized loss	(3)	(4)
Corporate subordinated debt
Debt Securities, Available-for-sale
Less than 12 months, fair value	3,957	4,032
Less than 12 months, unrealized loss	(76)	(3)
12 months or more, fair value	0	0
12 months or more, unrealized loss	0	0
Total, fair value	3,957	4,032
Total, unrealized loss	$ (76)	$ (3)

Investments - Schedule of other

Investments - Schedule of other investments (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Investments [Abstract]
Equity investments without readily determinable fair value	$ 2,731	$ 2,673

Loans and Allowance for Loan _3

Loans and Allowance for Loan and Lease Losses - Schedule of composition of loan portfolio (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 1,244,350	$ 1,223,857
Deferred costs, net	422	3,182
Allowance for loan and lease losses	(17,127)	(17,452)	$ (17,520)	$ (13,611)
Loans, net	$ 1,227,645	$ 1,209,587
Percentage of loan portfolio	100.00%	100.00%
Commercial loans, excluding PPP
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 321,319	$ 337,427
Allowance for loan and lease losses	$ (10,623)	$ (11,255)	(11,218)	(8,883)
Percentage of loan portfolio	25.80%	27.60%
Commercial loans, excluding PPP | Commercial loans - PPP
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 280,562	$ 229,728
Allowance for loan and lease losses	$ 0	$ 0	0	0
Percentage of loan portfolio	22.50%	18.80%
Commercial real estate loans – owner occupied
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 189,203	$ 197,336
Percentage of loan portfolio	15.20%	16.10%
Commercial real estate loans – all other
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 197,026	$ 194,893
Percentage of loan portfolio	15.80%	15.90%
Residential mortgage loans – multi-family
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 157,646	$ 159,182
Percentage of loan portfolio	12.70%	13.00%
Residential mortgage loans – single family
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 10,085	$ 12,766
Percentage of loan portfolio	0.80%	1.00%
Construction and land development loans
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 11,840	$ 11,766
Allowance for loan and lease losses	$ (166)	$ (137)	$ (55)	$ (34)
Percentage of loan portfolio	1.00%	1.00%
Consumer loans
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 76,669	$ 80,759
Percentage of loan portfolio	6.20%	6.60%

Loans and Allowance for Loan _4

Loans and Allowance for Loan and Lease Losses - Narrative (Details)	3 Months Ended
	Mar. 31, 2021USD ($)loan	Mar. 31, 2020USD ($)loan	Dec. 31, 2020USD ($)
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 1,244,350,000		$ 1,223,857,000
Loans and leases receivable sold	0	$ 0
Loans and leases receivable purchased	$ 0	0
Loans and leases receivable, allowance, length of historical and industry loss factors	4 years
Loans greater than 90 days and accruing, count | loan	0
Loans greater than 90 days and accruing			5,700,000
Impaired loans with no specific reserves	$ 11,287,000		19,958,000
Impaired loans, impaired in prior year	8,600,000
Interest that would have been earned had impaired loans remained current in accordance with original terms	424,000	$ 574,000
Troubled debt restructurings, totals	$ 9,100,000		6,700,000
Number of Loans | loan	8	0
Subsequent default, number of contracts | loan	0	0
Commercial loans, excluding PPP
Accounts, Notes, Loans and Financing Receivable
Gross loans	$ 321,319,000		337,427,000
Impaired loans with no specific reserves	5,627,000		10,970,000
Consumer loans
Accounts, Notes, Loans and Financing Receivable
Gross loans	76,669,000		80,759,000
Impaired loans with no specific reserves	181,000		174,000
Commercial loans - PPP
Accounts, Notes, Loans and Financing Receivable
Debt instrument forgiven	96,900,000
Commercial loans - PPP | Commercial loans, excluding PPP
Accounts, Notes, Loans and Financing Receivable
Gross loans	280,562,000		229,728,000
Federal Reserve Bank Of San Francisco | Commercial loans, excluding PPP
Accounts, Notes, Loans and Financing Receivable
Loans pledged to secure borrowings obtained from the FHLB and FRB	130,000,000
Federal Reserve Bank Of San Francisco | Consumer loans
Accounts, Notes, Loans and Financing Receivable
Loans pledged to secure borrowings obtained from the FHLB and FRB			146,000,000
Federal Home Loan Bank of San Francisco
Accounts, Notes, Loans and Financing Receivable
Loans pledged to secure borrowings obtained from the FHLB and FRB	$ 439,000,000		$ 434,000,000

Loans and Allowance for Loan _5

Loans and Allowance for Loan and Lease Losses - Summary of Activity in ALLL (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Allowance for Loan and Lease Losses
Balance at beginning of period	$ 17,452	$ 13,611
Charge offs	(538)	(2,314)
Recoveries	213	23
Provision	0	6,200
Balance at end of period	17,127	17,520
Commercial (excl PPP)
Allowance for Loan and Lease Losses
Balance at beginning of period	11,255	8,883
Charge offs	(525)	(2,250)
Recoveries	209	19
Provision	(316)	4,566
Balance at end of period	10,623	11,218
Commercial (excl PPP) | Commercial loans - PPP
Allowance for Loan and Lease Losses
Balance at beginning of period	0	0
Charge offs	0	0
Recoveries	0	0
Provision	0	0
Balance at end of period	0	0
Real Estate
Allowance for Loan and Lease Losses
Balance at beginning of period	3,964	2,897
Charge offs	0	0
Recoveries	0	0
Provision	489	1,471
Balance at end of period	4,453	4,368
Construction and land development loans
Allowance for Loan and Lease Losses
Balance at beginning of period	137	34
Charge offs	0	0
Recoveries	0	0
Provision	29	21
Balance at end of period	166	55
Consumer  and Single Family Mortgages
Allowance for Loan and Lease Losses
Balance at beginning of period	2,096	1,797
Charge offs	(13)	(64)
Recoveries	4	4
Provision	(202)	142
Balance at end of period	1,885	1,879
Unallocated
Allowance for Loan and Lease Losses
Balance at beginning of period	0	0
Charge offs	0	0
Recoveries	0	0
Provision	0	0
Balance at end of period	$ 0	$ 0

Loans and Allowance for Loan _6

Loans and Allowance for Loan and Lease Losses - Loan Balances and Related ALLL (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020	Dec. 31, 2019
Financing Receivable, Allowance for Credit Loss
Allowance for loans individually evaluated for impairment	$ 1,962	$ 2,711
Allowance for loans collectively evaluated for impairment	15,165	14,741
Total allowance	17,127	17,452	$ 17,520	$ 13,611
Loans individually evaluated for impairment	25,841	37,547
Loans collectively evaluated for impairment	1,218,509	1,186,310
Total	1,244,350	1,223,857
Commercial (excl PPP)
Financing Receivable, Allowance for Credit Loss
Allowance for loans individually evaluated for impairment	1,962	2,711
Allowance for loans collectively evaluated for impairment	8,661	8,544
Total allowance	10,623	11,255	11,218	8,883
Loans individually evaluated for impairment	20,452	30,886
Loans collectively evaluated for impairment	300,867	306,541
Total	321,319	337,427
Commercial (excl PPP) | Commercial loans - PPP
Financing Receivable, Allowance for Credit Loss
Allowance for loans individually evaluated for impairment	0	0
Allowance for loans collectively evaluated for impairment	0	0
Total allowance	0	0	0	0
Loans individually evaluated for impairment	0	0
Loans collectively evaluated for impairment	280,562	229,728
Total	280,562	229,728
Real Estate
Financing Receivable, Allowance for Credit Loss
Allowance for loans individually evaluated for impairment	0	0
Allowance for loans collectively evaluated for impairment	4,453	3,964
Total allowance	4,453	3,964	4,368	2,897
Loans individually evaluated for impairment	5,389	6,661
Loans collectively evaluated for impairment	538,486	544,751
Total	543,875	551,412
Construction and land development loans
Financing Receivable, Allowance for Credit Loss
Allowance for loans individually evaluated for impairment	0	0
Allowance for loans collectively evaluated for impairment	166	137
Total allowance	166	137	55	34
Loans individually evaluated for impairment	0	0
Loans collectively evaluated for impairment	11,840	11,766
Total	11,840	11,766
Consumer  and Single Family Mortgages
Financing Receivable, Allowance for Credit Loss
Allowance for loans individually evaluated for impairment	0	0
Allowance for loans collectively evaluated for impairment	1,885	2,096
Total allowance	1,885	2,096	1,879	1,797
Loans individually evaluated for impairment	0	0
Loans collectively evaluated for impairment	86,754	93,525
Total	86,754	93,525
Unallocated
Financing Receivable, Allowance for Credit Loss
Allowance for loans individually evaluated for impairment	0	0
Allowance for loans collectively evaluated for impairment	0	0
Total allowance	0	0	$ 0	$ 0
Loans individually evaluated for impairment	0	0
Loans collectively evaluated for impairment	0	0
Total	$ 0	$ 0

Loans and Allowance for Loan _7

Loans and Allowance for Loan and Lease Losses - Summary of delinquency status of loans by portfolio type (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Financing Receivable, Past Due
Total	$ 1,244,350	$ 1,223,857
Loans greater than 90 days and accruing		5,700
Commercial loans, excluding PPP
Financing Receivable, Past Due
Total	321,319	337,427
Commercial loans, excluding PPP | Commercial loans - PPP
Financing Receivable, Past Due
Total	280,562	229,728
Commercial real estate loans – owner occupied
Financing Receivable, Past Due
Total	189,203	197,336
Commercial real estate loans – all other
Financing Receivable, Past Due
Total	197,026	194,893
Residential mortgage loans – multi-family
Financing Receivable, Past Due
Total	157,646	159,182
Residential mortgage loans – single family
Financing Receivable, Past Due
Total	10,085	12,766
Construction and land development loans
Financing Receivable, Past Due
Total	11,840	11,766
Consumer loans
Financing Receivable, Past Due
Total	76,669	80,759
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration
Financing Receivable, Past Due
Past due	2,172	20,499
Current	1,242,178	1,203,358
Total	1,244,350	1,223,857
Loans greater than 90 days and accruing	0	5,675
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | 30-59 Days Past Due
Financing Receivable, Past Due
Past due	1,456	5,281
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | 60-89 Days Past Due
Financing Receivable, Past Due
Past due	93	3,711
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | 90 Days and Greater
Financing Receivable, Past Due
Past due	623	11,507
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial loans, excluding PPP
Financing Receivable, Past Due
Past due	2,025	18,597
Current	319,294	318,830
Total	321,319	337,427
Loans greater than 90 days and accruing	0	5,675
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial loans, excluding PPP | 30-59 Days Past Due
Financing Receivable, Past Due
Past due	1,367	5,281
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial loans, excluding PPP | 60-89 Days Past Due
Financing Receivable, Past Due
Past due	80	3,646
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial loans, excluding PPP | 90 Days and Greater
Financing Receivable, Past Due
Past due	578	9,670
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial loans, excluding PPP | Commercial loans - PPP
Financing Receivable, Past Due
Past due	0	0
Current	280,562	229,728
Total	280,562	229,728
Loans greater than 90 days and accruing	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial loans, excluding PPP | Commercial loans - PPP | 30-59 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial loans, excluding PPP | Commercial loans - PPP | 60-89 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial loans, excluding PPP | Commercial loans - PPP | 90 Days and Greater
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial real estate loans – owner occupied
Financing Receivable, Past Due
Past due	0	0
Current	189,203	197,336
Total	189,203	197,336
Loans greater than 90 days and accruing	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial real estate loans – owner occupied | 30-59 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial real estate loans – owner occupied | 60-89 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial real estate loans – owner occupied | 90 Days and Greater
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial real estate loans – all other
Financing Receivable, Past Due
Past due	0	1,837
Current	197,026	193,056
Total	197,026	194,893
Loans greater than 90 days and accruing	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial real estate loans – all other | 30-59 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial real estate loans – all other | 60-89 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Commercial real estate loans – all other | 90 Days and Greater
Financing Receivable, Past Due
Past due	0	1,837
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Residential mortgage loans – multi-family
Financing Receivable, Past Due
Past due	0	0
Current	157,646	159,182
Total	157,646	159,182
Loans greater than 90 days and accruing	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Residential mortgage loans – multi-family | 30-59 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Residential mortgage loans – multi-family | 60-89 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Residential mortgage loans – multi-family | 90 Days and Greater
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Residential mortgage loans – single family
Financing Receivable, Past Due
Past due	0	0
Current	10,085	12,766
Total	10,085	12,766
Loans greater than 90 days and accruing	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Residential mortgage loans – single family | 30-59 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Residential mortgage loans – single family | 60-89 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Residential mortgage loans – single family | 90 Days and Greater
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Construction and land development loans
Financing Receivable, Past Due
Past due	0	0
Current	11,840	11,766
Total	11,840	11,766
Loans greater than 90 days and accruing	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Construction and land development loans | 30-59 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Construction and land development loans | 60-89 Days Past Due
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Construction and land development loans | 90 Days and Greater
Financing Receivable, Past Due
Past due	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Consumer loans
Financing Receivable, Past Due
Past due	147	65
Current	76,522	80,694
Total	76,669	80,759
Loans greater than 90 days and accruing	0	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Consumer loans | 30-59 Days Past Due
Financing Receivable, Past Due
Past due	89	0
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Consumer loans | 60-89 Days Past Due
Financing Receivable, Past Due
Past due	13	65
Financial Asset, Other than Financial Asset Acquired with Credit Deterioration | Consumer loans | 90 Days and Greater
Financing Receivable, Past Due
Past due	$ 45	$ 0

Loans and Allowance for Loan _8

Loans and Allowance for Loan and Lease Losses - Loans on Nonaccrual Status by Portfolio Type (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Financing Receivable Recorded Investment Nonaccrual Status
Nonaccrual loans:	$ 20,559	$ 39,916
Commercial loans, excluding PPP
Financing Receivable Recorded Investment Nonaccrual Status
Nonaccrual loans:	19,426	30,928
Commercial real estate loans – owner occupied
Financing Receivable Recorded Investment Nonaccrual Status
Nonaccrual loans:	952	6,978
Commercial real estate loans – all other
Financing Receivable Recorded Investment Nonaccrual Status
Nonaccrual loans:	0	1,836
Consumer loans
Financing Receivable Recorded Investment Nonaccrual Status
Nonaccrual loans:	$ 181	$ 174

Loans and Allowance for Loan _9

Loans and Allowance for Loan and Lease Losses - Summary of loans by portfolio type and internal credit quality ratings (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Financing Receivable, Credit Quality Indicator
Gross loans	$ 1,244,350	$ 1,223,857
Pass:
Financing Receivable, Credit Quality Indicator
Gross loans	1,169,686	1,111,782
Special Mention:
Financing Receivable, Credit Quality Indicator
Gross loans	11,636	21,804
Substandard:
Financing Receivable, Credit Quality Indicator
Gross loans	62,921	89,630
Doubtful:
Financing Receivable, Credit Quality Indicator
Gross loans	107	641
Commercial loans, excluding PPP
Financing Receivable, Credit Quality Indicator
Gross loans	321,319	337,427
Commercial loans, excluding PPP | Commercial loans - PPP
Financing Receivable, Credit Quality Indicator
Gross loans	280,562	229,728
Commercial loans, excluding PPP | Pass:
Financing Receivable, Credit Quality Indicator
Gross loans	271,240	263,616
Commercial loans, excluding PPP | Pass: | Commercial loans - PPP
Financing Receivable, Credit Quality Indicator
Gross loans	280,562	229,728
Commercial loans, excluding PPP | Special Mention:
Financing Receivable, Credit Quality Indicator
Gross loans	10,667	13,763
Commercial loans, excluding PPP | Substandard:
Financing Receivable, Credit Quality Indicator
Gross loans	39,305	59,408
Commercial loans, excluding PPP | Doubtful:
Financing Receivable, Credit Quality Indicator
Gross loans	107	641
Commercial real estate loans – owner occupied
Financing Receivable, Credit Quality Indicator
Gross loans	189,203	197,336
Commercial real estate loans – owner occupied | Pass:
Financing Receivable, Credit Quality Indicator
Gross loans	167,057	162,250
Commercial real estate loans – owner occupied | Special Mention:
Financing Receivable, Credit Quality Indicator
Gross loans	0	6,882
Commercial real estate loans – owner occupied | Substandard:
Financing Receivable, Credit Quality Indicator
Gross loans	22,145	28,203
Commercial real estate loans – all other
Financing Receivable, Credit Quality Indicator
Gross loans	197,026	194,893
Commercial real estate loans – all other | Pass:
Financing Receivable, Credit Quality Indicator
Gross loans	196,243	192,264
Commercial real estate loans – all other | Special Mention:
Financing Receivable, Credit Quality Indicator
Gross loans	0	793
Commercial real estate loans – all other | Substandard:
Financing Receivable, Credit Quality Indicator
Gross loans	783	1,837
Residential mortgage loans – multi-family
Financing Receivable, Credit Quality Indicator
Gross loans	157,646	159,182
Residential mortgage loans – multi-family | Pass:
Financing Receivable, Credit Quality Indicator
Gross loans	156,678	158,816
Residential mortgage loans – multi-family | Special Mention:
Financing Receivable, Credit Quality Indicator
Gross loans	969	366
Residential mortgage loans – single family
Financing Receivable, Credit Quality Indicator
Gross loans	10,085	12,766
Residential mortgage loans – single family | Pass:
Financing Receivable, Credit Quality Indicator
Gross loans	10,085	12,766
Construction and land development loans
Financing Receivable, Credit Quality Indicator
Gross loans	11,840	11,766
Construction and land development loans | Pass:
Financing Receivable, Credit Quality Indicator
Gross loans	11,340	11,766
Construction and land development loans | Substandard:
Financing Receivable, Credit Quality Indicator
Gross loans	500	0
Consumer loans
Financing Receivable, Credit Quality Indicator
Gross loans	76,669	80,759
Consumer loans | Pass:
Financing Receivable, Credit Quality Indicator
Gross loans	76,481	80,576
Consumer loans | Substandard:
Financing Receivable, Credit Quality Indicator
Gross loans	$ 188	$ 182

Loans and Allowance for Loan_10

Loans and Allowance for Loan and Lease Losses - Nonaccrual Loans and Restructured Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Impaired loans:
Nonaccruing loans	$ 17,064	$ 33,204
Nonaccruing restructured loans	3,495	6,712
Accruing restructured loans	5,589	0
Total impaired loans	26,148	39,916
Impaired loans less than 90 days delinquent and included in total impaired loans
Impaired loans:
Total impaired loans	$ 25,525	$ 34,085

Loans and Allowance for Loan_11

Loans and Allowance for Loan and Lease Losses - Additional Information with Respect to Impaired Loans, by Portfolio Type (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Financing Receivable, Impaired
Recorded investment, no allowance recorded	$ 11,287		$ 19,958
Recorded investment, with allowance recorded	14,861		19,958
Total impaired loans	26,148		39,916
Unpaid principal balance, no allowance recorded	18,355		29,197
Unpaid principal balance, with allowance recorded	15,041		20,040
Unpaid Principal Balance	33,396		49,237
Related allowance	1,962		2,711
Average balance, no allowance recorded	15,622	$ 16,746
Average balance, with allowance recorded	17,410	1,105
Average Balance	33,032	17,851
Interest income recognized, no allowance recorded	54	0
Interest income recognized, with allowance recorded	0	0
Interest Income Recognized	54	0
Commercial loans, excluding PPP
Financing Receivable, Impaired
Recorded investment, no allowance recorded	5,627		10,970
Recorded investment, with allowance recorded	14,861		19,958
Total impaired loans	20,488		30,928
Unpaid principal balance, no allowance recorded	11,935		19,530
Unpaid principal balance, with allowance recorded	15,041		20,040
Unpaid Principal Balance	26,976		39,570
Related allowance	1,962		2,711
Average balance, no allowance recorded	8,298	10,178
Average balance, with allowance recorded	17,410	1,105
Average Balance	25,708	11,283
Interest income recognized, no allowance recorded	54	0
Interest income recognized, with allowance recorded		0
Interest Income Recognized	54	0
Commercial real estate loans – owner occupied
Financing Receivable, Impaired
Recorded investment, no allowance recorded	5,479		6,978
Total impaired loans	5,479		6,978
Unpaid principal balance, no allowance recorded	6,198		7,633
Unpaid Principal Balance	6,198		7,633
Related allowance	0		0
Average balance, no allowance recorded	6,228	6,438
Average Balance	6,228	6,438
Interest income recognized, no allowance recorded	0	0
Interest Income Recognized	0	0
Commercial real estate loans – all other
Financing Receivable, Impaired
Recorded investment, no allowance recorded	0		1,836
Total impaired loans	0		1,836
Unpaid principal balance, no allowance recorded	0		1,837
Unpaid Principal Balance	0		1,837
Average balance, no allowance recorded	918	0
Average Balance	918	0
Interest income recognized, no allowance recorded	0	0
Interest Income Recognized	0	0
Consumer loans
Financing Receivable, Impaired
Recorded investment, no allowance recorded	181		174
Total impaired loans	181		174
Unpaid principal balance, no allowance recorded	222		197
Unpaid Principal Balance	222		197
Related allowance	0		$ 0
Average balance, no allowance recorded	178	130
Average Balance	178	130
Interest income recognized, no allowance recorded	0	0
Interest Income Recognized	$ 0	$ 0

Loans and Allowance for Loan_12

Loans and Allowance for Loan and Lease Losses - schedule of loans restructured as TDRs (Details)	3 Months Ended
	Mar. 31, 2021USD ($)loan	Mar. 31, 2020USD ($)loan
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of Loans | loan	8	0
Pre-Modification Outstanding Recorded Investment	$ 12,834,000	$ 0
Post-Modification Outstanding Recorded Investment	$ 9,084,000	$ 0
Performing Financial Instruments
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of Loans | loan	3	0
Pre-Modification Outstanding Recorded Investment	$ 7,568,000	$ 0
Post-Modification Outstanding Recorded Investment	$ 5,589,000	$ 0
Nonperforming Financial Instruments
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of Loans | loan	5	0
Pre-Modification Outstanding Recorded Investment	$ 5,266,000	$ 0
Post-Modification Outstanding Recorded Investment	$ 3,495,000	$ 0
Commercial loans, excluding PPP | Performing Financial Instruments
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of Loans | loan	2	0
Pre-Modification Outstanding Recorded Investment	$ 2,639,000	$ 0
Post-Modification Outstanding Recorded Investment	$ 1,062,000	$ 0
Commercial loans, excluding PPP | Nonperforming Financial Instruments
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of Loans | loan	5	0
Pre-Modification Outstanding Recorded Investment	$ 5,266,000	$ 0
Post-Modification Outstanding Recorded Investment	$ 3,495,000	$ 0
Commercial real estate loans – owner occupied | Performing Financial Instruments
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of Loans	1	0
Pre-Modification Outstanding Recorded Investment	$ 4,929,000	$ 0
Post-Modification Outstanding Recorded Investment	$ 4,527,000	$ 0

Leases - Narrative (Details)

Leases - Narrative (Details) - lease	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Leases [Abstract]
Number of operating leases with multiple optional renewal periods	2
Operating lease, weighted average discount rate, percent	2.31%	2.31%

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Leases [Abstract]
Operating lease cost	$ 605	$ 609
Short-term lease cost	37	35
Total lease cost	$ 642	$ 644
Weighted-average remaining lease term—operating leases (in years)	4 years 1 month 13 days	5 years 1 month 13 days

Leases - Schedule of Supplement

Leases - Schedule of Supplemental Balance Sheet Information (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating Lease, Right-of-Use Asset, Statement of Financial Position	Other assets	Other assets
Operating right-of-use assets	$ 9,457	$ 10,002
Operating Lease, Liability, Statement of Financial Position	Other liabilities	Other liabilities
Operating lease liabilities	$ 10,383	$ 10,933

Leases - Schedule of Suppleme_2

Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash paid for amounts included in the measurement of lease liabilities
Operating cash flows from operating leases (fixed payments)	$ 610	$ 572
Noncash activities:
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 0	$ 0

Leases - Schedule of Operating

Leases - Schedule of Operating Lease Liability Maturities (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Remainder of 2021	$ 1,879
2022	2,575
2023	2,662
2024	2,750
2025	1,021
2025 and beyond	0
Total	10,887
Less: Imputed interest	(504)
Total Lease liabilities	$ 10,383	$ 10,933

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ 1,425,000	$ (991,000)
Deferred tax assets, valuation allowance	$ 0	$ 0

Stock-Based Employee Compensa_3

Stock-Based Employee Compensation Plans - Narrative (Details) $ in Thousands	1 Months Ended	3 Months Ended
	May 31, 2019shares	Mar. 31, 2021USD ($)shares	Mar. 31, 2020USD ($)shares	Dec. 31, 2020USD ($)shares	Dec. 31, 2019shares
Share-based Compensation Arrangement by Share-based Payment Award
Options outstanding (in shares)		573,587	638,660	589,587	1,009,466
Granted (in shares)		0	0
Options exercised (in shares)		16,000	10,728
Aggregate intrinsic value of options exercised | $		$ 38	$ 29
Fair value of options vested | $		59	83
Aggregate intrinsic values of options outstanding and exercisable | $		$ 713		$ 30
Nonvested awards, expected weighted average recognition period (years)		3 years 3 months 25 days
Aggregate amounts of stock based compensation expense, net of taxes | $		$ 159	$ 151
Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Purchase price per share of common stock as percentage of fair market value of shares on respective grant dates of stock options		100.00%
Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Options, restricted shares and SARs, vesting period		5 years
Options and SARs, terms after date of grant		10 years
Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award
Unvested shares (in shares)		194,247	103,695	123,165	124,202
Unvested shares granted during the period (shares)		112,970	37,739
Restricted stock | Directors
Share-based Compensation Arrangement by Share-based Payment Award
Options, restricted shares and SARs, vesting period		1 year
Restricted stock | Minimum | Employees
Share-based Compensation Arrangement by Share-based Payment Award
Options, restricted shares and SARs, vesting period		3 years
Restricted stock | Maximum | Employees
Share-based Compensation Arrangement by Share-based Payment Award
Options, restricted shares and SARs, vesting period		5 years
Stock Units
Share-based Compensation Arrangement by Share-based Payment Award
Unvested shares (in shares)		75,000	100,000	75,000	100,000
Unvested shares granted during the period (shares)		0	0
Stock Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Options, restricted shares and SARs, vesting period		1 year
Stock Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Options, restricted shares and SARs, vesting period		5 years
Previously Approved Equity Incentive Plans
Share-based Compensation Arrangement by Share-based Payment Award
Options outstanding (in shares)		0
Equity Incentive Plan 2010
Share-based Compensation Arrangement by Share-based Payment Award
Additional shares authorized (in shares)	0
Equity Incentive Plan 2019
Share-based Compensation Arrangement by Share-based Payment Award
Number of shares authorized (in shares)	2,000,000
Number of shares available for future grants (in shares)		1,039,830
Equity Incentive Plan 2019 | Stock units
Share-based Compensation Arrangement by Share-based Payment Award
Unvested shares (in shares)		75,000
Unvested shares granted during the period (shares)		158,894
Common stock | Equity Incentive Plan 2010
Share-based Compensation Arrangement by Share-based Payment Award
Options outstanding (in shares)		323,587
Common stock | Equity Incentive Plan 2019
Share-based Compensation Arrangement by Share-based Payment Award
Options outstanding (in shares)		250,000
Common stock | Equity Incentive Plan 2019 | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award
Share conversion rate from previous plan (in shares)		2.5
Common stock | Equity Incentive Plan 2019 | SARs
Share-based Compensation Arrangement by Share-based Payment Award
Share conversion rate from previous plan (in shares)		1
Restricted stock | Equity Incentive Plan 2010 | Restricted stock
Share-based Compensation Arrangement by Share-based Payment Award
Options outstanding (in shares)		35,353

Stock-Based Employee Compensa_4

Stock-Based Employee Compensation Plans - Schedule of stock option activity under plans (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Number of Shares
Outstanding, beginning of period (in shares)	589,587	1,009,466
Granted (in shares)	0	0
Exercised (in shares)	(16,000)	(10,728)
Forfeited/Canceled (in shares)	0	(360,078)
Outstanding, end of period (in shares)	573,587	638,660
Option Exercisable, end of period (in shares)	361,545	344,581
Options Vested, end of period (in shares)	361,545	344,581
Weighted- Average Exercise Price Per Share
Weighted Average Exercise Price, beginning of period (in dollars per share)	$ 7.01	$ 6.98
Granted (in dollars per share)	0	0
Exercised (in dollars per share)	4.34	4.66
Forfeited/Canceled (in dollars per share)	0	6.92
Weighted Average Exercise Price, end of period (in dollars per share)	7.09	7.05
Options Exercisable, end of period (in dollars per share)	6.93	6.74
Options Vested, end of period (in dollars per share)	$ 6.93	$ 6.74

Stock-Based Employee Compensa_5

Stock-Based Employee Compensation Plans - Vested and unvested options outstanding (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020	Mar. 31, 2020	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award
Options outstanding, vested (in shares)	361,545		344,581
Options outstanding, unvested (in shares)	212,042
Options outstanding, weighted average exercise price (in dollars per share)	$ 7.09	$ 7.01	$ 7.05	$ 6.98
Options outstanding, weighted average remaining contractual life (years)	6 years 1 month 28 days
Options exercisable (in shares)	361,545		344,581
Options exercisable, weighted average exercise price (in dollars per share)	$ 6.93		$ 6.74
Options exercisable, weighted average remaining contractual life	4 years 10 months 28 days
$2.97 – $3.99
Share-based Compensation Arrangement by Share-based Payment Award
Option outstanding, exercise price, lower limit (in dollars per share)	$ 2.97
Option outstanding, exercise price, upper limit (in dollars per share)	$ 3.99
Options outstanding, vested (in shares)	12,000
Options outstanding, unvested (in shares)	0
Options outstanding, weighted average exercise price (in dollars per share)	$ 3.74
Options outstanding, weighted average remaining contractual life (years)	9 months 25 days
Options exercisable (in shares)	12,000
Options exercisable, weighted average exercise price (in dollars per share)	$ 3.74
$4.00 – $5.99
Share-based Compensation Arrangement by Share-based Payment Award
Option outstanding, exercise price, lower limit (in dollars per share)	4
Option outstanding, exercise price, upper limit (in dollars per share)	$ 5.99
Options outstanding, vested (in shares)	0
Options outstanding, unvested (in shares)	0
Options outstanding, weighted average exercise price (in dollars per share)	$ 0
Options outstanding, weighted average remaining contractual life (years)	0 years
Options exercisable (in shares)	0
Options exercisable, weighted average exercise price (in dollars per share)	$ 0
$6.00 – $6.99
Share-based Compensation Arrangement by Share-based Payment Award
Option outstanding, exercise price, lower limit (in dollars per share)	6
Option outstanding, exercise price, upper limit (in dollars per share)	$ 6.99
Options outstanding, vested (in shares)	202,189
Options outstanding, unvested (in shares)	5,450
Options outstanding, weighted average exercise price (in dollars per share)	$ 6.61
Options outstanding, weighted average remaining contractual life (years)	3 years 10 months 13 days
Options exercisable (in shares)	202,189
Options exercisable, weighted average exercise price (in dollars per share)	$ 6.60
$7.00 – $7.99
Share-based Compensation Arrangement by Share-based Payment Award
Option outstanding, exercise price, lower limit (in dollars per share)	7
Option outstanding, exercise price, upper limit (in dollars per share)	$ 7.99
Options outstanding, vested (in shares)	84,157
Options outstanding, unvested (in shares)	200,000
Options outstanding, weighted average exercise price (in dollars per share)	$ 7.30
Options outstanding, weighted average remaining contractual life (years)	7 years 10 months 17 days
Options exercisable (in shares)	84,157
Options exercisable, weighted average exercise price (in dollars per share)	$ 7.24
$8.00 – $8.40
Share-based Compensation Arrangement by Share-based Payment Award
Option outstanding, exercise price, lower limit (in dollars per share)	8
Option outstanding, exercise price, upper limit (in dollars per share)	$ 8.40
Options outstanding, vested (in shares)	63,199
Options outstanding, unvested (in shares)	6,592
Options outstanding, weighted average exercise price (in dollars per share)	$ 8.21
Options outstanding, weighted average remaining contractual life (years)	6 years 10 months 24 days
Options exercisable (in shares)	63,199
Options exercisable, weighted average exercise price (in dollars per share)	$ 8.19

Stock-Based Employee Compensa_6

Stock-Based Employee Compensation Plans - Summary of status of unvested options and changes in number of shares subject to and in weighted average grant date fair values of unvested options (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Number of Shares Subject to Options
Granted (in shares)	0	0
Unvested, end of period (in shares)	212,042
Stock options
Number of Shares Subject to Options
Unvested, beginning of period (in shares)	233,107	334,322
Granted (in shares)	0	0
Vested (in shares)	(21,065)	(29,409)
Forfeited/canceled (in shares)	0	(10,834)
Unvested, end of period (in shares)	212,042	294,079
Weighted Average Grant Date Fair Value Per Share
Unvested, beginning of period (in dollars per share)	$ 2.10	$ 2.19
Granted (in dollars per share)	0	0
Vested (in dollars per share)	2.81	2.81
Forfeited/canceled (in dollars per share)	0	2.82
Unvested, end of period (in dollars per share)	$ 2.03	$ 2.11

Stock-Based Employee Compensa_7

Stock-Based Employee Compensation Plans - Stock unit activity (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Restricted stock
Number of Shares
Outstanding, at beginning of period (in shares)	123,165	124,202
Granted (in shares)	112,970	37,739
Vested (in shares)	(41,888)	(39,889)
Forfeited (in shares)	0	(18,357)
Outstanding, at end of period (in shares)	194,247	103,695
Average Grant Date Fair Value Per Share
Outstanding, at beginning of period (in dollars per share)	$ 6.63	$ 8.44
Granted (in dollars per share)	6.68	6.99
Vested (in dollars per share)	7.71	8.59
Forfeited (in dollars per share)	0	8.25
Outstanding, at end of period (in dollars per share)	$ 6.43	$ 7.90
Stock Units
Number of Shares
Outstanding, at beginning of period (in shares)	75,000	100,000
Granted (in shares)	0	0
Vested (in shares)	0	0
Forfeited (in shares)	0	0
Outstanding, at end of period (in shares)	75,000	100,000
Average Grant Date Fair Value Per Share
Outstanding, at beginning of period (in dollars per share)	$ 7.33	$ 7.33
Granted (in dollars per share)	0	0
Vested (in dollars per share)	0	0
Forfeited (in dollars per share)	0	0
Outstanding, at end of period (in dollars per share)	$ 7.33	$ 7.33

Stock-Based Employee Compensa_8

Stock-Based Employee Compensation Plans - Compensation expense expected to be recognized (Details) $ in Thousands	Mar. 31, 2021USD ($)
Share-based Compensation Arrangement by Share-based Payment Award
Remainder of 2021	$ 717
2022	619
2023	361
2024	115
2024 and beyond	10
Estimated Stock Based Compensation Expense Total	1,822
Estimated Stock Based Compensation Expense Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Remainder of 2021	85
2022	109
2023	101
2024	67
2024 and beyond	0
Estimated Stock Based Compensation Expense Total	362
Estimated Stock Based Compensation Expense Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award
Remainder of 2021	448
2022	346
2023	260
2024	48
2024 and beyond	10
Estimated Stock Based Compensation Expense Total	1,112
Estimated Stock Based Compensation Expense Stock Units
Share-based Compensation Arrangement by Share-based Payment Award
Remainder of 2021	184
2022	164
2023	0
2024	0
2024 and beyond	0
Estimated Stock Based Compensation Expense Total	$ 348

Earnings Per Share ("EPS") - Sc

Earnings Per Share ("EPS") - Schedule of computation of basic and diluted earnings per share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Basic EPS:
Net income (loss)	$ 3,388	$ (2,361)
Net income (loss) allocable to common shareholders	3,388	(2,361)
Less earnings allocated to participating securities	33	0
Earnings (loss) allocated to common shareholders	$ 3,355	$ (2,361)
Weighted average common shares outstanding (in shares)	23,561,643	23,475,042
Basic earnings (loss) per common share (in dollars per share)	$ 0.14	$ (0.10)
Diluted EPS:
Earnings (loss) allocated to common shareholders	$ 3,388	$ (2,361)
Weighted average diluted common shares outstanding (in shares)	23,813,329	23,475,042
Diluted earnings (loss) per common share (in dollars per share)	$ 0.14	$ (0.10)
Restricted stock
Diluted EPS:
Add dilutive effects of restricted stock grants and stock options (in shares)	158,000	0
Stock units
Diluted EPS:
Add dilutive effects of restricted stock grants and stock options (in shares)	75,000	0
Stock options
Diluted EPS:
Add dilutive effects of restricted stock grants and stock options (in shares)	18,000	0

Earnings Per Share ("EPS") - _2

Earnings Per Share ("EPS") - Schedule of antidilutive securities excluded from earnings per share (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share
Anti-dilutive shares excluded from computation of earnings per share (in shares)	377,198	800,960

Shareholders' Equity - Schedule

Shareholders' Equity - Schedule of accumulated other comprehensive income (loss), net (Details) - USD ($) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Dec. 31, 2019
Accumulated Other Comprehensive Income (Loss), Net of Tax
Beginning balance	$ 158,749	$ 149,048	$ 149,048
Other comprehensive (loss) income, net of tax	(1,161)	547
Ending balance	161,271	147,498	158,749	$ 149,048
Other comprehensive income, tax	487		202
Unrealized Gain (Loss) on Securities Available-for-Sale, net of tax
Accumulated Other Comprehensive Income (Loss), Net of Tax
Beginning balance	(84)	(567)	(567)	(1,144)
Other comprehensive (loss) income, net of tax	(1,161)		483	577
Ending balance	(1,245)		(84)	(567)
Other comprehensive income, tax	487		202	62
Accumulated Other Comprehensive Income (Loss), Net
Accumulated Other Comprehensive Income (Loss), Net of Tax
Beginning balance	(84)	(567)	(567)	(1,144)
Other comprehensive (loss) income, net of tax	(1,161)	547	483	577
Ending balance	$ (1,245)	$ (20)	$ (84)	$ (567)

Commitments and Contingencies_2

Commitments and Contingencies - Narrative (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Commitment And Contingencies
Loss reserve for unfunded loan commitments	$ 350,000	$ 350,000
Unused borrowing capacity		242,000,000
Maximum borrowings outstanding at any month-end		124,000,000
FHLB advances—short-term	0	10,000,000
FHLB advances—long-term		0
Federal Reserve Bank Of San Francisco
Commitment And Contingencies
Unused borrowing capacity	94,000,000	106,000,000
Federal Reserve Bank Of San Francisco | Consumer loans
Commitment And Contingencies
Loans pledged as collateral to support FHLB and FRB borrowings	130,000,000	146,000,000
Federal Reserve Bank Of San Francisco | Commercial loans, excluding PPP
Commitment And Contingencies
Loans pledged as collateral to support FHLB and FRB borrowings	130,000,000	$ 146,000,000
Federal Home Loan Bank of San Francisco
Commitment And Contingencies
Loans pledged as collateral to support FHLB and FRB borrowings	439,000,000
Unused borrowing capacity	286,000,000
Maximum borrowings outstanding at any month-end	10,000,000
FHLB Advances
Commitment And Contingencies
Weighted-average annualized interest rate		1.62%
Letter of credit
Commitment And Contingencies
Commitment to fund certain loans including letter of credit	$ 341,000,000	$ 347,000,000

Commitments and Contingencies_3

Commitments and Contingencies - Schedule of borrowings and contractual obligations (Details) - USD ($) $ in Thousands	Mar. 31, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
FHLB advances—short-term	$ 0	$ 10,000
Total	$ 0	$ 10,000

Business Segment Information _2

Business Segment Information - Narrative (Details)	3 Months Ended
	Mar. 31, 2021segment
Segment Reporting [Abstract]
Reportable business segment	1

Business Segment Information _3

Business Segment Information - Schedule of net interest income and noninterest income (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Segment Reporting Information
Net interest income	$ 12,739	$ 11,473
Noninterest Income	1,738	1,095
Assets	1,580,037		$ 1,587,590
Operating Segments | Commercial
Segment Reporting Information
Net interest income	12,861	11,670
Noninterest Income	1,734	1,089
Assets	1,579,123		1,586,916
Other
Segment Reporting Information
Net interest income	(122)	(197)
Noninterest Income	4	$ 6
Assets	$ 914		$ 674

Regulatory Capital - Schedule o

Regulatory Capital - Schedule of actual amount and capital ratios of company and bank (Details) - Bank $ in Thousands	Mar. 31, 2021USD ($)
Total Capital to Risk Weighted Assets
Total capital to risk weighted assets, actual capital amount	$ 187,050
Total capital to risk weighted assets, actual capital ratio	0.168
Total capital to risk weighted assets, for capital adequacy purposes, amount	$ 133,331
Total capital to risk weighted assets to be categorized as well-capitalized, amount	111,678
Tier 1 capital to risk weighted assets
Tier 1 capital to risk weighted assets, actual capital amount	$ 173,047
Tier 1 capital to risk weighted asset, actual capital ratio	0.155
Tier 1 risk based capital required for capital adequacy	$ 73,987
Tier 1 capital to risk weighted assets, to be categorized as well capitalized, amount	89,343
Tier 1 Capital to Average Assets
Tier 1 capital to average assets, actual capital amount	$ 173,047
Tier 1 capital to average asset, actual capital ratio	0.112
Tier 1 capital to average assets, for capital adequacy purposes, amount	$ 61,835
Tier 1 capital to risk weighted assets, to be categorized as well capitalized, amount	$ 77,294
Minimum
Total Capital to Risk Weighted Assets
Total capital to risk weighted assets, for capital adequacy purposes, ratio	0.08625
Total capital to risk weighted assets to be categorized as well-capitalized, ratio	0.100
Tier 1 capital to risk weighted assets
Tier 1 capital to risk weighted assets, for capital adequacy purposes, ratio	0.06625
Tier 1 capital to risk weighted assets, to be categorized as well capitalized, ratio	0.080
Tier 1 Capital to Average Assets
Tier 1 capital to average assets, for capital adequacy purposes, ratio	0.040
Tier 1 leverage capital required to be well capitalized to average assets	0.050
Common stock
Tier 1 capital to risk weighted assets
Tier 1 capital to risk weighted assets, actual capital amount	$ 173,047
Tier 1 capital to risk weighted asset, actual capital ratio	0.155
Tier 1 risk based capital required for capital adequacy	$ 57,235
Tier 1 capital to risk weighted assets, to be categorized as well capitalized, amount	$ 72,591
Common stock | Minimum
Tier 1 capital to risk weighted assets
Tier 1 capital to risk weighted assets, for capital adequacy purposes, ratio	0.05125
Tier 1 capital to risk weighted assets, to be categorized as well capitalized, ratio	0.065

Risk and Uncertainties (Details

Risk and Uncertainties (Details) $ in Millions	Mar. 31, 2021USD ($)
Risks and Uncertainties [Abstract]
Percentage of employees working remotely (percent)	25.00%
Excess capital	$ 75
Capital available for bank contributions	$ 10